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          As a major component of the nuclear lamina, the type V intermediate filament 
proteins called lamins are important for the structure and function of the nucleus. Lamins 
are subdivided into A- and B-types. B-type lamins are implicated in the regulation of 
many aspects of nuclear function. However, the role of lamins in the context of adult 
organ maintenance and tissue aging remains largely unknown. Thymic involution, which 
is an age-related regression of the thymus, causes a decline in naive T cell production and 
is mainly responsible for immune senescence. The underlying mechanism for this process 
is still poorly understood. I developed a novel flow cytometry based method to quantify 
the protein level of nuclear lamins in vivo. By applying this new tool to the thymus, the 
primary immune organ for T-cell development, I identified an age-associated reduction of 
lamin-B1 in thymic epithelial cells (TECs). I further demonstrated that macrophage- and 
dendritic cell-derived proinflammatory cytokines led to lamin-B1 reduction in TECs via 
cellular senescence. I found that TEC-specific deletion of Lmnb1, but not Lmnb2 or 
Lmna, leads to thymic atrophy and a number of changes in the TEC compartment that are 
remarkably similar to reported age-related defects. I also demonstrated that lamin-B1 is 
required for proper antigen presentation in TECs and that lamin-B1 deficiency in TECs 
leads to inefficient positive and negative selection of T cells.  My RNA-seq data strongly 
suggest that Lmnb1-loss-mediated transcriptome change contributes, at least in part, to 
the age-associated change in the transcriptional program in TECs and that this in turn 
leads to the observed degenerative phenotypes. 
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Chapter 1: Introduction  
Overview 
My thesis research is divided into two parts. Part 1 involves the study of lamin-B1 
in tissue homeostasis. Part 2 is devoted to develop method to enable chromatin 
immunoprecipitation-seq (ChIP-seq). Below I introduce each of the two subjects of my 
thesis separately. 
 
I. Thymic involution, inflammation and nuclear lamins 
Aging is characterized by a progressive loss of tissue homeostasis and function, 
and is believed to underly many age-associated diseases. The age-associated deterioration 
of the immune system, often referred to as immunosenescence, leads to decreased 
immune function and is considered to be a major cause of increased morbidity and 
mortality in the elderly. Immunosenescence is accompanied by pronounced age-related 
changes in the thymus, a primary lymphoid organ involved in T-cell development, and 
ultimately results in a decline in naïve T-cell production. The degeneration of the thymus 
marked by dramatic size reduction, termed thymic involution, remains a fundamental 
conundrum in immunology as it becomes apparent much earlier than other immune 
organs and is detrimental to the maintenance of adaptive immunity.  
While thymic epithelial cells (TECs) have been well documented as the major cell 
type responsible for involution, very little is known about the cellular and molecular 
mechanisms underlying age-associated alterations in TECs with considerable effort 
instead focused on the identification of markers of TEC subpopulations. Due to the 
general paucity and heterogeneity of TECs, genome-wide transcriptome and epigenome 
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analyses in specific subpopulations of TECs have not been well studied to date but 
represent an area of intense interest in the contexts of general TEC biology and in aging. 
Further, despite remarkable morphological and structural changes documented in the 
thymic epitelium upon aging, understanding how age-associated alterations lead to the 
reorganization of cellular structures in TECs and how defective cell structures cause the 
aging phenotypes is still lacking. My thesis work was inspired by our recent pioneering 
work uncovering a novel mechanism by which age-associated loss of lamin-B, the major 
component of the nuclear structure, in Droshophila immune organ fat body triggers 
systemic inflammation and immunosenescence (Chen et al., 2014).  
A better understanding of the complex mechanisms mediating thymic involution 
is essential to design effective therapeutic approaches to improve immune function in 
aged individuals. Herein I will limit my review on the mechanisms governing TEC 
development and their potential roles in regulating postnatal thymic homeostasis and 
involution. I will include outstanding questions that have not yet been resolved, with 
special emphasis on the role of inflammation in involution. Additionally, I will introduce 
the role of nuclear lamins in inflammation, tissue homeostasis and aging. 
 
Thymic epithelial cells form niches for T-cell development 
The thymus is a major site of T-cell development and is required for robust 
adaptive immunity in vertebrates (Anderson and Takahama, 2012). The development of 
the thymus is intimately linked to that of the parathyroid gland as they both arise from the 
same endodermal primordium in the third pharyngeal pouch during early embryogenesis 
(Gordon et al., 2004). Ventral-region restricted expression of the thymus-specific 
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transcription factor Foxn1 (Forkhead Box N1) and complementary dorsal-region 
expression of the parathyroid transcription factor GCM2 (Glial Cells Missing Homolog 
2) defines the boundary between these two organs within the third pharyngeal pouch 
(Gordon et al., 2001). The importance of Foxn1 for thymus development and function is 
demonstrated by the severe immunocompromised phenotypes typical of athymic “nude” 
mice and human subjects bearing mutation alleles (Nehls et al., 1994; Palamaro et al., 
2014). While Foxn1 is not required for the initial specification of thymus fate as Foxn1-
null thymic rudiment exhibits some early TEC markers (Nehls et al., 1996), it is essential 
for proper differentiation and proliferation of TEC after fate commitment (Blackburn et 
al., 1996; Nowell et al., 2011). The initial seeding of hematopoietic stem cells (HSCs) in 
mouse thymus starts as early as embryonic day 11.5 (E11.5) (Jotereau et al., 1987) and 
the signals from developing thymocytes also provide essential inductive information for 
proper TEC development (Klug et al., 1998). The mutual interactions between TECs and 
developing thymocytes, termed as “cross-talk”, are required for proper organization of 
thymic stromal architecture (Anderson and Jenkinson, 2001; Klug et al., 1998; Klug et al., 
2002). 
The postnatal thymus is composed of developing T cells, known as thymocytes, 
and non-lymphoid stromal cells that comprise the different niche microenvironments that 
promote the various stages of thymocyte development. Whereas the thymic stromal cells 
only constitute ~1% total cellularity of the thymus, they play the central role in nurturing 
and educating thymocyte differentiation and maturation. The thymic stromal 
compartment consists of thymic epithelial cells (TEC), mesenchyme, endothelial and 
non-lymphoid hematopoietic cells such as dendritic cell (DC) and macrophage. Among 
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these, TECs represent the primary stromal cell type essential for mediating distinct stages 
of thymocyte development (Anderson and Takahama, 2012). TECs form a complex 3-
dimentional (3D) network and are organized into two discrete regions or compartments 
that comprise different subtypes of TECs and thymocytes (Gordon and Manley, 2011; 
Manley et al., 2011). The inner and outer compartments are called the medulla and cortex, 
respectively; and the region where they contact is the corticomedullary junction (CMJ) 
and is known as the site of T-cell progenitors homing and export of mature naïve T cells 
(Lind et al., 2001; Mori et al., 2001; Takahama, 2006). The medulla and cortex consist of 
two morphologically and functionally distinct TEC subsets, medullary epithelial cell 
(mTEC) and cortical epithelial cell (cTEC), respectively. Recent studies suggest that both 
mTEC and cTEC are heterogeneous and identification of detailed markers to delineate 
TEC subpopulations attracts extensive interest in the field (Nowell et al., 2011; Ohigashi 
et al., 2015; Wong et al., 2014). 
T-cell development within the thymus involves extensive cell migration through 
the cortex and medulla, and interaction with distinct TEC-formed niches that ensure the 
proper selection of immuno-competent T cells (Fig. 1-1). Initial interaction with the 
Notch ligands expressed on cTECs specifies the T-cell fate within the early thymic 
progenitor (ETP) population. T-lineage specified thymocytes migrate through the cortex 
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Fig 1-1. An overview of αβ T-cell development in the thymus. In the postnatal thymus, 
HSC-derived T-lymphoid progenitors (ETP) migrate into the thymus via blood vessels at 
the corticalmedullary junction region (CMJ). Early committed T cells lack expression of 
CD4 and CD8 and thus are referred to double-negative (DN) thymocytes. During 
migration from CMJ to subcapsular zone, DN thymocytes process through four stages 






















double-positive (DP) cells that express T-cell receptor (TCR) recognizing self-peptides 
associated with MHC (pMHC) class I (for CD8) or II (for CD4) molecules expressed on 
cTECs. Positive selection, which exclusively depends on cTECs, induces DP cells with 
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intrathymic migration of immature thymocytes (Benz et al., 2004; Misslitz et al., 2004; 
Plotkin et al., 2003). DP cells then migrate back from subcapsular zone towards the 
corticomedullary junction (Fig. 1-1), during which they are subjected to the first key 
selection process, often referred to as positive selection. Positive selection, which 
exclusively depends on cTEC, induces DP cells with functional T-cell receptors (TCRs) 
that bind to antigen peptide whithin MHC complex (pMHC) on antigen presenting cells 




 single-positive (SP) thymocytes. 
More than 90% DP cells expressing non-functional TCRs die by neglect (Anderson and 





 SP cells then move cross the CMJ and relocate into the medulla, where they 
undergo a quality screening process known as negative selection or clonal deletion. 
mTEC and DC are the two main cell types responsible for negative selection, through 
which SP cells with high-affinity TCRs for self-pMHC are induced to die via apoptosis, 
ensuring only self-tolerant T cells survive (Klein et al., 2009). Promiscuous expression of 
peripheral tissue-restricted antigens (TRA) in mTEC has been demonstrated to play a 
central role in governing mTEC-mediated negative selection. Two key transcription 
factors, Autoimmune regulator (Aire) and Fezf2, function in concert to regulate distinct 
panels of TRA expression in mTEC to ensure immune tolerance (Anderson et al., 2002; 
Takaba et al., 2015). In addition to mediating clonal deletion, an intact mTEC 
compartment is essential for generation of Foxp3
+
 thymic regulatory T cells (tTregs) as 
tTreg cells with intermediate-affinity for self-pMHC are preferentially induced for 
survival via clonal deviation but not clonal deletion in the medulla region (Aschenbrenner 
et al., 2007; Cowan et al., 2013). A functional thymus guarantees that only self-MHC 
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restricted mature T cells with no self-reactive potential are exported to establish the 
adaptive immune system. 
 
Mechanisms of TEC development, maintenance and degeneration 
A handful of genes and signaling pathways have been characterized in TECs and 
linked with the development, maintenance and involution of the thymus (Fig. 1-2). One 
key transcriptional factor, forkhead box protein N1 (Foxn1), has been extensively studied 
over the past two decades and is well documented as a regulator of TEC biology, tying 
together TEC development, maintenance and degeneration. Foxn1 was initially cloned 
from the classic athymic nude mouse mutant and functional analyses demonstrated that 
Foxn1 was required for proper TEC differentiation and proliferation after fate 
commitment, as Foxn1-null TECs were arrested at the stem/progenitor stage (Nehls et al., 
1996). In contrast to its central role in embryonic TEC development, the role of Foxn1 in 
the postnantal thymus is much less characterized. The further regulation of Foxn1 in 
various TEC subsets in the postnantal thymus adds additional layers of complexity, 
which make it difficult to dissect the function of this important transcription factor 
(Nowell et al., 2011; O'Neill et al., 2016; Rode et al., 2015). Three lines of evidence 
suggest that Foxn1 is a key regulator of TEC maintenance and function in the postnatal 
thymus. First, the Manley group reported diminished Foxn1 expression in Foxn1
lacz/lacz 
alleles in 1-week old postnantal thymus, resulting in accelerated thymic degeneration 
(Chen et al., 2009). Second, early mouse studies indicate that down-regulation of Foxn1 




Fig 1-2. A summary of mechanisms involved in TEC development, maintenance and 
degeneration. While Foxn1 is not required for TEC-lineage commitment from TEC stem 
cells, it is essential for bipotent TEC progenitors to differentiate into either cTEC or 
mTEC sublineages and also plays a critical role in regulating proliferation of TEC subsets. 
Signaling pathways through TNF receptor (TNFR) super family members (RANK, CD40 
and LTβR) play critical roles in inducing mTEC lineage development, however, it is still 
unknown which signaling pathway(s) derives cTEC lineage differentiation. FGF family 
members, such as KGF and FGF21, play a crucial role in regulating TEC proliferation in 
both fetal and postnatal thymus. The prevalent view suggests that down-regulation of 
Foxn1 expression and/or protein in TECs in the postnatal thymus triggers thymic 
involution, however, recent evidence fails to support this concept. Increased expression 
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of intrathymic inflammatory cytokines from dendritic cell and macrophage are known to 
play an important role in inducing age-associated alternation in TECs and leading to 
thymic involution. 





















(Cheng et al., 2010; Ortman et al., 2002; Sun et al., 2010). Finally, transgenic mouse lines 
with overexpression of Foxn1 show 4-6 months delayed thymic involution (Zook et al., 
2011), and forced TEC-specific upregulation of Foxn1 in involuted thymus leads to 
robust thymic regeneration characterized by increased thymopoiesis and naïve T-cell 
output (Bredenkamp et al., 2014). Thus, the Foxn1 expression and function is generally 
accepted as the prime mediator of thymus involution (Boehm and Swann, 2013). 
However, this notion requires a careful evaluation as several recent studies did not find a 
clear age-related down-regulation of Foxn1 mRNA and/or protein levels during thymic 
involution (Ki et al., 2014; O'Neill et al., 2016; Rode et al., 2015). For example, using a 
reporter, Foxn1
G
 allele that is different from the one used by the Manley group, to 
moniter protein level of Foxn1 during embryogenesis and involution, the Blackburn 
group showed that there was no signicificant change of Foxn1 protein level in TEC 
subsets between 3-month and up to 20-month old mouse thymus, indicating that Foxn1 
may not be physiologically involved in age-associated thymic involution (O'Neill et al., 
2016). Since Foxn1
lacz/lacz 
alleles used by Manley group resulted in artificial down-
regulation of Foxn1 expression in TECs, the findings reported by Foxn1
G
 allele from 
Blackburn group were likely to reflect bona fida expression of Foxn1 in TEC subsets 
during aging. Given that the thymus eventually undergoes involution even with sustained 
Foxn1 expression, further research is need to to identify Foxn1-independent mechanisms 
or pathways in thymic senescence.  
Several cytokines have been shown to have thymostimulatory effects and improve 
thymopoiesis in aged mouse thymus. Fibroblast growth factor (FGF) family has recently 
received much attention as they exhibit potential for thymic regeneration. Keratinocyte 
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growth factor (KGF), also known as FGF7, has been well characterized in the TEC field 
as another key factor for thymic aging and regeneration. Signaling through the main 
receptor, FGF2R-IIIb, KGF has been demonstrated to play a vital role for fetal thymic 
organogenesis and for maintaining the integrity of the postnantal thymus via modulating 
TEC proliferation (Dooley et al., 2007; Erickson et al., 2002; Revest et al., 2001). 
Administration of KGF also increases thymic cellularity, enhances thymic thymopoiesis 
and naïve T-cell production, and accelerates T-cell functional reconstitution in aged 
mouse (Alpdogan et al., 2006; Min et al., 2007; Rossi et al., 2002; Rossi et al., 2007). 
Another FGF member, FGF21 (liver-derived metabolic hormone), has recently been 
identified as an immune-metabolic regulator that links metabolic and immune system to 
prevent T-cell immune senescence (Youm et al., 2016). Genetic overexpression of 
FGF21 significantly eliminates intrathymic adipocytes, restores TEC stromal architecture 
and augments naïve T-cell production in aged mouse thymus (Youm et al., 2016). These 
results suggest that approaches aimed at enhancing FGF21 signaling will lead to thymic 
rejuvenation and delay immune senescence, and will be of great therapeutic value.  
Age-associated changes of intrathymic inflammatory cytokines have recently 
been documented as another category of mediators driving thymic involution. Early work 
analyzing human thymus samples revealed that thymic aging is associated with 
significantly elevated expression of proinflmamtory cytokines such as IL-6 family 
members, including IL-6, leukemia inhibitory factor (Lif) and oncostatin (OSM). The 
experimental administration of IL-6 family members induced acute thymic atrophy in 
murine models, suggesting an active role of inflammation in thymic senescence with 
aging (Sempowski et al., 2000; Sempowski et al., 2002). Global transcriptional profiling 
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of distinct thymic stromal cell subsets revealed that acquisition of proinflammatory 
features in myeloid lineage cells, sirp
+
 DC and macrophage, represented the earliest 
molecular hallmarks during early thymic involution (Ki et al., 2014). This includes up-
regulation of TNFα, IL-1α, IL-1β and IL-6, which have been implicated to play a role in 
the late stage of thymic involution. Interestingly, genetic overexpression of human TNF 
in mouse whole body induces a thymic atrophy phenotype with minimal effects on other 
immune organs/tissues, suggesting that the thymus is a sensitive immune tissue subject to 
inflammation insult (Liepinsh et al., 2009). Conversely, genetic ablation of components 
in NLRP3 inflammasome complex in macrophage to block production of IL-1β 
significantly delays age-related thymic atrophy and reduces intrathymic adipocytes, 
indicating that anti-inflammation may represent an effective means to delay or even 
prevent age-related thymic demise and improve T-cell mediated immune functions in the 
elderly (Youm et al., 2013; Youm et al., 2012). Consistent with this, anti-inflammatory 
Leptin has been shown to have therapeutic potential to protect against inflammation-
induced murine thymic atrophy (Aschenbrenner et al., 2007). Whereas inflammatory 
cytokines are unambiguously involved in aged-related thymic degeneration, the direct 
effects of these cytokines on TECs have not determined because most research focus on 
intrathymic changes in the whole thymus organ (Billard et al., 2011). Since TECs are the 
primary cell types responsible for age-related involution and since senescence and 
cellular morphological changes have been well documented in the aged thymus (Aw et al., 
2008; Palmer, 2013), one of the key questions remaining is how inflammatory cytokines 
lead to intracellular architectural changes in TECs and how defective structural changes 
induce TEC aging phenotypes.  
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Nuclear lamins link inflammation to tissue homeostasis and aging 
In eukaryotic cells, the nucleus is the major organelle that stores, replicates and 
transcribes genetic information. The nucleus is enclosed by a double-membrane nuclear 
envelope, which separates cytoplasmic and nuclear compartments. The nuclear lamina 
(NL), a major structural meshwork underneath nuclear envelope, has recently gained 
more interest because mutations in components of the NL are the main causes of a 
spectrum of human diseases known as laminopathies (Schreiber and Kennedy, 2013). 
The major components of the NL are the A-type and B-type nuclear lamins, which are the 
type V intermediate filament (IF) proteins critically important for the structural properties 
of the nucleus. In mammals, Lmna (mouse) expresses all A-type lamins including lamin-
A, lamin-C (collectively termed as lamin-A/C) and other splicing isoforms. There are two 
major mammalian B-type lamins: lamin-B1 and lamin-B2. They are ubiquitously 
expressed in somatic cells and are encoded by Lmnb1 and Lmnb2 (mouse), respectively. 
Lamin-B3 is a testis-specific lamin protein derived from Lmnb2 by alternative splicing.  
Lamins have been implicated in the regulation of numerous nuclear processes, 
such as nuclear assembly, DNA replication, transcriptional regulation, and chromatin 
organization (Burke and Stewart, 2013; Dechat et al., 2008). Consequently, B-type 
lamins have been assumed as housekeeping proteins necessary for basic cell viability. 
However, more recent studies from our lab demonstrate that mouse embryonic stem cells 
(mESCs) lacking all lamins can still self-renew and undergo differentiation into different 
cell types in vitro (Kim et al., 2011; Kim et al., 2013). Therefore, lamins are not required 
for survival at least in mESCs. B-type lamins are also reported to be dispensable for 
certain cell types such as the skin keratinocytes and hepatocytes in vivo (Yang et al., 
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2011). The studies of lamins in different model organisms indicate that B-type lamins are 
required for proper development of some but not all organs during organogenesis (i.e., 
brain, diaphragm, testis) (Chen et al., 2013; Kim et al., 2011), indicating that B-type 
lamins may function in a cell-type dependent manner. New work from our lab further 
demonstrates that the assembly of each lamin into the NL and the location of other 
nuclear proteins depend primarily on the total lamin protein concentration present in the 
nucleus, suggesting that cells or tissues may exhibit different requirements for a specific 
lamin protein (Guo et al., 2014; Guo and Zheng, 2015). These findings provide new 
insights into the mechanism by which B-type lamins exhibit differential effects on the 
building of different organs in vivo. 
In additional to developmental functions, lamin-B1 has recently been suggested to 
be involved in regulating tissue maintenance and aging. Replicative senescence of in 
vitro cultured mammalian fibroblasts has long been shown to be associated with lamin-
B1 reduction, alteration of nuclear structure and chromatin organization, and increased 
secretion of inflammatory cytokine (Campisi, 2013; Freund et al., 2012; Kuilman et al., 
2010). This senescence phenomenon is also called senescence-associated secretory 
phenotype (SASP) (Coppe et al., 2008). With respect to mechanism, activation of either 
tumor suppressor Rb or p53 is sufficient to induce lamin-B1 reduction and cellular 
senescence (Freund et al., 2012; Shimi et al., 2011). Further evidence suggests that lamin-
B1 loss is a key trigger of global and local chromatin landscape changes that can impact 
gene expression in senescence (Sadaie et al., 2013; Shah et al., 2013). In addition, lamin-
B1 reduction is also observed in senescence-prone cells derived from Progeria patients 
(premature aging) with shorten telomeres, indicating that lamin-B1 reduction may further 
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enhance cellular aging (Scaffidi and Misteli, 2005). Thus, lamin-B1 loss or reduction is 
proposed as a new biomarker of cellular senescence. 
Whereas cellular senescence induced by Rb and p53 can lead to lamin-B1 
reduction during cellular aging in tissue cultures, it remains largely unknown whether 
lamin-B1 reduction occurs in vivo upon aging since it is difficult to quantify lamin 
protein level in mammalian tissues composed of heterogeneous cell types derived from 
different origins. A direct link between lamin-B1 loss and tissue homeostasis and/or 
aging came from our lab’s recent study of the role of lamin-B in the Drosophila immune 
organ called the fat body (Chen et al., 2014). Lamin-B reduction, but not A-type lamin, 
was apparent in cells of fat body upon aging and it induced age-associated systemic 
inflammation via up-regulation of the immune deficiency (IMD, equivalent to 
mammalian TNFa signaling pathway) signaling pathway, leading to increased secretion 
of circulating inflammatory cytokines, peptidoglaycan recognition proteins (PGRPs). 
Elevated circulating PGRPs in turn repress the IMD activity in the midgut and trigger 
overproliferation of intestinal stem cells and gut hyperplasia in aged flies (Fig. 1-3). Of 
interest, the immune response genes are significantly enriched in lamin-B associated 
chromatin domains, also known as LADs. Considering that lamins are known to repress 
gene expression, age-related lamin-B loss may de-repress the expression of immune 
genes, especially inflammatory cytokines, inducing local inflammation and tissue 
deterioration. While it has long been suspected that some cell-intrinsic defects may 
contribute to age-related chronic inflammation (inflammaging) (Franceschi et al., 2000), 
this study in fly provided the first line evidence by identifying a single nuclear defect, the 




Fig 1-3. A model for age-related lamin-B loss-induced systemic inflammation in fly. 
Loss of lamin-B occurs in the cells in fat body in old fly, which in turn leads to 
derepression of inflammatory cytokines secreted into the circulation. Elevated circulating 
inflammatory cytokines then repress the local immune response in the midgut and result 
in over-proliferation and inappropriate differentiation of intestinal stem cells and gut 








homeostasis. Interestingly, lamin-B loss does not occur in all tissues in the fly upon aging, 
suggesting that age-associated lamin-B loss occurs in a cell-type and tissue-specific 
manner. Thus, a systematic examination to establish which cell/tissue type(s) undergoes 
age-related reduction of lamin-B in mammals would provide clues to the cause and 
consequence of lamin loss in vivo. Deciphering how aging results in lamin-B loss and the 
consequence of lamin-B loss should provide new insights into the mechanisms mediating 
human diseases that result from aging-associated tissue deterioration. One part of my 
thesis work has focused on using the thymic TECs as a model to investigate how lamin-
B1 contributes to immune tissue homeostasis and function. A better understanding of 
how lamin-B1 regulates immune homeostasis will aid the identification of new 
therapeutic targets that improve immune function in aged individuals. In Charpter 2, I 
will report a new method to quantify the protein level of nuclear lamins and identification 
of an age-associated reduction of lamin-B1 phenotype in TECs. In Charpter 3, I will 
focus on characterization of lamin-B1 functions in TECs. In Charpter 4, I will talk about 
lamin-B1-mediated transcriptional signatures in TECs based on RNA-seq data. 
 
II. ChIP-seq: an emerging genome-wide profiling techology 
Understanding how lamins, especially lamin-B1, regulate chromatin/genome 
organization and gene transcription is critical to decipher the underlying mechanism by 
which lamin-B1 loss contributes to tissue damage and aging in vivo. With recent 
technological progress and increased affordability of the next-generation sequencing 
techology, Chromatin immunoprecipitation coupled with sequencing (ChIP-seq) has 
become a widely used approach for genome-wide mapping of transcription/chromatin 
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regulatory factor binding and histone modifications as it offers higher resolution, fewer 
artefacts and substantially improved data quality compared to its counterpart ChIP-chip 
(Park, 2009). Due to significant DNA loss during multiple-step manipulations (Fig. 1-4) 
and inefficient ligation step in library preparation, standard ChIP-seq methods generally 
require large amounts of starting material (~10 ng enriched DNA or >10
6
 cells) for 
reliable and high-quality mapping which significantly precludes its application to rare 
cell populations in vivo, such as stem and/or progenitors cells (Furey, 2012; Park, 2009). 
Recently, several groups reported novel ChIP-seq protocols to minimize the required cell 
number and adapatation for in vivo application. In this section, I will briefly describe 
recent progress in developing new ChIP-seq methods and emphasize on their advantages 
and possible drawbacks.  
Pre-amplication of ChIP enriched DNA (ChIPed DNA) before sequencing library 
preparation allows the scaling down of the initial cell number requirement to as few as 
10
4
 cells. LinDA-ChIP-seq (single-tube linear DNA amplification) has been applied to 
profiling of the oestrogen receptor-a (ERa) and histone H3K4 trimethlyation (H3K4Me3) 
modification using 10,000 cells (Shankaranarayanan et al., 2011). The key to this 
protocol is to ligate adaptors with T7 promoter to ChIPed DNA and then convert DNA to 
more RNA molecules throught T7 RNA polymerase-mediated linear amplification. Pre-
amplifed RNAs are then converted to DNA for further sequencing library preparation. 
While it avoids amplification bias common in PCR-based approaches, the reproducibility 
of this protocol fails to meet the standard criterion for 80% precision by ENCODE 
project. Another method, called Nano-ChIP-seq, pre-amplifies the small amount of 






Fig 1-4. An overview of a ChIP-seq experiment. Left: profiling of histone 










self-annealing during PCR amplification (Adli et al., 2010). The hairpin primers contain a 
restriction site that allows ligation of illumina adaptors for direct sequencing. Although it 
has been applied for mapping chromatin modifications histone H3 lysine 4 trimethylation 
(H3K4Me3) and histone H3 lysine 27 trimethylation (H3K27Me3) in 10,000 sorted 
mouse bone marrow hematopoietic progenitor cells, it relies on increasing amplification 
cycles (4 cycles of primer extension and 5 more cycles of PCR than the Illumina standard 
protocol) and introduces increased amounts of mapping bias and unmapped reads in the 
final sequencing library. The major defect of these two protocols is failure to protect 
DNA loss during ChIP procedure as low-abundance ChIPed DNA may be 
underrepresented or lost before any kind of pre-amplication methods. 
An alternative approach is to perform barcoding to first label fragmented 
chromatin in individual samples and then pooling of multiple chromatin-barcoded 
samples for ChIP in the same reaction. The first implementation of this principle, called 
indexing-first ChIP-seq (iChIP), reported a significant reduction of the intial cell number 
for ChIP-seq even down to a few hundred cells (Lara-Astiaso et al., 2014). While this 
protocol dramatically reduces DNA loss by sample pooling, ligation of barcoding 
adaptors to chromatin fragments is performed on magnetic beads, which dramatically 
reduces ligation efficiency. Indeed, the new work published by the same group showed 
that only 2-3% of chromatin fragments were added barcoding adaptors (Gury-BenAri et 
al., 2016), indicating that more than 97% of initial material was lost in this protocol for 
final ChIP-seq and thus 10,000-20,000 sorted hematopoietic stem cells (HSCs) were used 
in their original iChIP-seq database. Three recent publications report updated versions of 
this protocol, which introduce T7-promoter to barcoding adaptors to allow combination 
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of chromatin-barcoding pooling and T7-mediated pre-amplication of ChIPed DNA 
(Rotem et al., 2015; van Galen et al., 2016; Weiner et al., 2016). With the aid of new 
approach, the Amit group recently provided a comprenhesive genome-wide mapping of 
co-occurrence of 14 histone modifications in primary bone marrow derived dendritic 
cells (BMDC) and reported previously undescribed co-occurrence patterns such as co-
existence of H3K9 monomethlyation (H3K9Me1) and H3K27 acetylation (H3K27ac) in 
super-enhancers (Weiner et al., 2016). While these studies are promising, a later study 
showed that the improved protocals only gave 7-8% recovery of T7-barcoded chromatin 
and still incurred more than 90% loss of chromatin (Gury-BenAri et al., 2016), 
preventing these approaches for general application to rare cell populations in vivo.  
Micrococcal nuclease (MNase) is commonly used to digest uncrosslinked 
chromatin and is generally preferred in epigenetic profiling with a small cell number 
input since it removes linker DNA more efficiently than sonication, which allows more 
precise mapping at a single nucleosome resolution. Recently, an optimized MNase-based 
native Uli-NChIP-seq (Ultra-low-input Native ChIP-seq) was reported to profile genome-
wide histone modifications using as few as 10
3
 mESCs (Brind'Amour et al., 2015). While 
Uli-NChIP-seq offers acceptable mapping quality for abundant histone modifications 
such as H3K9Me3 and H3K27Me3 using 10
3
 cells, it still suffers significant loss of 
ChIPed DNA and requires ~10,000 cells for reliable profiling of less abundant markers 
like H3K4Me3. 
Despite much progress made from above mentioned approaches, a common 
defect from these methods is failure to consider protection of material during multiple-
step processing in ChIP-seq, precluding reliable high-quality profiling in low cell number 
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application in vivo. In the last chapter of the thesis, I will report a new strategy for high-
fidelity genome-wide profiling using as few as 500 cells and its application in the study 
of hematopoiesis. 
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The nuclear lamins have recently been suggested to play important roles in tissue 
building, homeostasis and aging. An age-associated reduction of B-type but not A-type 
lamin has been reported in cells in fat body from old Drosophila and contributes to 
heterochromatin loss and derepression of immune response genes, which in turn triggers 
systemic inflammation and tissue dysfunction. How aging triggers cell/tissue-specific 
lamin-B loss is not well understood. A systematic examination to identify which 
cell/tissue type(s) undergoes age-related reduction of lamins should provide clues to the 
cause(s) of loss. To achieve this aim, I developed a novel flow cytometry based method 
to quantify the protein level of nuclear lamins. By applying this new tool to the thymus, 
the primary immune organ for T-cell development, I identified an age-associated 
reduction of lamin-B1 in thymic epithelial cells (TECs). I further demonstrated that 
macrophage- and dendritic cell-derived proinflammatory cytokines led to lamin-B1 
reduction in TECs, at least in part via cellular senescence. This new method is readily 
adaptable to other cell types from any tissue/organ by incorporating cell-specific 
marker(s), which should open doors to further investigate how advanced age leads to 







Much effort has been devoted to study the functions of nuclear lamins in 
development and tissue homeostasis since the discovery that mutations in lamins and 
other components of the nuclear lamina (NL) cause a spectrum of rare human diseases 
collectively called laminopathies (Benedetti and Merlini, 2004; Gruenbaum et al., 2005; 
Mounkes et al., 2003). The recent mouse and Drosophila genetic studies have shown that 
lamins are required for proper development of multiple organs during organogenesis 
(Chen et al., 2013; Coffinier et al., 2010; Coffinier et al., 2011; Kim et al., 2011). Further 
studies are needed to dissect the mechanism by which lamins function in tissue building. 
Interestingly, lamin-B1 reduction has recently been linked to cellular senescence, which 
has been implicated in tissue aging and age-related diseases (Campisi, 2013; Campisi and 
d'Adda di Fagagna, 2007; Childs et al., 2015). Induction of cellular senescence is 
accompanied by nuclear lamin-B1 reduction in cultured primary cells in vitro, and lamin-
B1 reduction occurs upon forced expression of oncogene Ras or activation of the 
downstream Rb or P53 tummor suppressor, both of which trigger senescence or cellular 
aging (Dreesen et al., 2013a; Dreesen et al., 2013b; Freund et al., 2012; Shimi et al., 
2011). These in vitro findings suggest that nuclear lamin-B1 may contribute to tissue 
degenerative process via cellular senescence. In vivo, our lab reported for the first time 
that lamin-B loss in the cells in Drosophila immune organ, the fat body, led to systemic 
inflammation and tissue dysfunction, providing new insights into cause and consequence 
of immunosenescence during aging (Chen et al., 2014). However, the relevance of this to 
natural aging in mammals is unknown. Due to the complexity of cellular composition in 
mammalian tissue/organ(s), it is intrinsically difficult to quantify alterations in lamin 
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expression and identify which cell type(s) lose lamins during natural aging. In addition, 
standard immunofluorescence (IF) and Western blotting techniques are time-consuming 
and are not suitable for systematic survey of cell/tissue types that undergo aging-related 
lamin alteration. This poses a significant impediment to deciphering how lamins function 
in the process of tissue maintenance and aging.  
To solve the technical issues in properly quantifying lamins in specific cell types, 
I herein report the development of a new flow cytometry-based method using the 
mammalian immune system. Applying this methodology to the mouse thymus, I find a 
specific reduction of nuclear lamin-B1, but not lamin-B2 or Lamin-A/C, in thymic 
epithelial cells upon aging. The extent of lamin-B1 reduction correlates with a 
progressive reduction of the total cell number in the thymus, suggesting that age-
associated lamin-B1 reduction in TECs contributes to thymus degeneration. I will focus 




Establishment of flow cytometry-based method to quantify nuclear lamins 
The major issue associated with using IF to assess lamin protein levels is time-consuming 
due in part to the low efficacy of preparing multiple samples for cryosection slides, IF 
picture capture and post image processing. Western blotting also involves multiple steps 
and it usually takes 2-3 days to complete the whole process. To overcome these 




Fig 2-1. Flow cytometer-based method to quantify nuclear lamins. (A) Schematic 
diagram of procedure of the approach. (B) FACS histogram overlay of lamin-B1, lamin-
B2 and lamin-A/C in WT mESCs (black solid line) and TKO mESCs (black dash line). 
Grey lines show lamin signals in IgG control. (C) Immunofluorescence images indicate 
lamin-B1 staining in the nuclear periphery of WT mESCs. Scale bars, 10 m. 
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method for measuring nuclear lamins in individual cell types (see Materials and Methods 
and Fig. 2-1A). True-Nuclear Trascription Factor staining buffer has been optimized for 
intracellular staining with minimum effect on the surface marker staining since the 
method relies on different combinations of surface markers to distinguish distinct 
subtypes within the same tissue/organ. To validate the specificity of this assay, I first 
used Fluorescence-activated cell sorting (FACS) to compare fluorescence signal intensity 







 triple KO or TKO) mouse embryonic stem cells (mESCs). In all tested 
lamin-TKO mESCs, I found fluorescence signal from the IgG control similar to 
background staining level (Fig. 2-1B), demonstrating the specificity of this method. To 
further confirm staining of lamins in the nucleus rather than non-specific binding to other 
components within cells, I applied FACS sorting to collect WT and TKO mESCs with 
lamin-B1 staining and adhered sorted mESCs to glass slides using cytospin. Then I 
examined the localization of lamin-B1 staining by confocal microscope. The confocal 
images demonstrated that this assay indeed detected the lamin-B1 at the nuclear 
periphery surrounding DAPI signal of DNA in the nucleus of WT mESCs (Fig. 2-1C).  
 
Identification of lamin-B1 reduction in TECs in aged mouse thymus 
Since the thymus is the first immune organ to undergo degeneration, I decided to 
test whether nuclear lamins play a role in this process. I first applied the lamin FACS 
assay to compare protein levels of all three lamins (lamin-B1/B2 and -A/C) in major cell 
types between 2-month-old young and 20-month-old aged wild-type (WT) mouse thymus. 




Fig 2-2. Lamin-B1 reduction in TECs correlates with thymic involution. (A) FACS 













) isolated from 2-month-old 
young (blue line) and 20-month-old aged WT mouse thymus (red line). MFI: Mean 
fluorescence intensity. (B) Quantification of lamin-B1 MFI in thymocytes and TECs 
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between young and aged thymus from (A). MFI of lamin-B1 of thymocytes or TECs in 
young (2-month-old) mouse thymus is defined as 1. (C) FACS histogram overlay of 
lamin-B2 (left) and lamin-A/C (right) in mTECs and cTECs isolated from 2-month-old 
young (blue line) and 20-month-old aged WT thymus (red line). (D) Western blotting 
analyses of lamin-B1 and lamin-A/C in thymocytes, mTECs and cTECs from 2-month-
old young and 20-month-old aged WT thymus. β-actin is used as a loading control. (E) 
Quantification of lamin-B1 MFI in mTECs (blue line) and cTECs (red line) in different 
stage thymuses, ranging from 2-month to 20-month of age. Total cell number of 
thymocytes (black line) shows age-related involution. Thymocyte cell number and MFI 
of lamin-B1 in TECs from 2-month-old thymus are defined as 1. All raw data of other 
time points are plotted relative to 2-month-old thymus. One representative Western 
blotting result of 2 independent experiments is shown for (D) and all other data shown 
are representative of at least 3 independent experiments. Error bars indicate SD of the 
mean from 3 independent experiments. Student’s t test: *, P < 0.05; **, P < 0.01; ***, P 










protein in all examined hematopoietic stem cell (HSC) derived cells in the aged mouse 
thymus, including thymocyte subpopulations, macrophage and dendritic cell (DC) (data 
not shown; see Materials and Methods). Consistent with previous reports, I found that the 
expression of lamin-A/C in HSC-derived cells was significant lower compared to that of 
lamin-B1 or -B2. Thus, I did not include lamin-A/C analysis in HSC-derived cells in the 
aged thymus. Of interest, FACS analyses of mTECs and cTECs from 20-month-old aged 
mouse thymus showed a significant reduction of lamin-B1 in both cell types compared to 
that in 2-month-old young counterparts (Fig. 2-2A). I further used mean fluorescence 
intensity (MFI) to quantify the extent of lamin-B1 reduction. To simplify the comparison, 
I defined the MFI of lamin-B1 in young mouse thymus as 1. I found that there was more 
than 65% reduction of lamin-B1 protein in both aged mTEC and cTEC, but not in T cells 
(Fig. 2-2B). In order to test whether other lamins also exhibited similar reduction trends 
as shown in lamin-B1, I further assessed the protein levels of lamin-B2 and -A/C in both 
mTECs and cTECs between young and aged mouse thymus. However, I did not observe 
any significant change of either lamin-B2 or lamin-A/C under these conditions (Fig. 2-
2C), suggesting that reduction of lamin-B1 but not lamin-B2 and -A/C specifically occurs 
in mTECs and cTECs in aged mouse thymus. In addition, I also applied Western blotting 
(Fig. 2-2D) and IF (data not shown) to assess lamin-B1 and -A/C protein levels in FACS-
sorted TECs. The results of these tests further confirm the reduction of lamin-B1 in both 
mTECs and cTECs in the aged mouse thymus.  
In order to gain more insights into the dynamics of lamin-B1 reduction in TECs 
and how this relates to the process of thymic involution, I further applied the lamin FACS 
assay to assess lamin-B1 protein levels in both mTECs and cTECs from different stages 
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of mouse thymus ranging from 2-month to 20-month of age.  Since thymic involution 
leads to a reduction of thymocytes in the thymus, counts of thymocytes in different stage 
thymuses were used as an indicator for the degeneration process (Fig. 2-2E). I observed 
that the earliest time point of significant lamin-B1 reduction in both mTECs and cTECs 
occurred in ~6-month-old thymus, which coincided with the degeneration process of the 
thymus. Based on the curves of thymocyte counts and lamin-B1 levels, thymus involution 
trend continued with the trend of lamin-B1 reduction in TECs. This suggests that lamin-
B1 reduction in TECs could be involved in thymic involution. 
 
Age-associated increase of pro-inflammatory cytokines in the thymus leads to lamin-
B1 reduction in TECs 
Transcriptional profiling of thymic stromal subsets during early thymic involution 
revealed an augmented pro-inflammatory signature in DC subpopulation (Ki et al., 2014). 
Thymic macrophage has also been suggested to contribute to thymic involution via 
enhanced secretion of pro-inflammatory cytokines upon thymic aging, and genetic 
blockage of inflammasome activation in macrophage delays age-related thymic atrophy 
(Youm et al., 2012). Since inflammation in thymus appears at ~6 months, which 
coincides with the onset of lamin-B1 reduction in TECs and thymic degeneration (Fig. 2-
2E), I reasoned that increased pro-inflammatory cytokines from thymic macrophage and 
DC might cause lamin-B1 reduction in TECs. In order to better understand the change of 
inflammation status in the thymus upon aging, I first applied FACS sorting to collect 
macrophage and DC subsets from the thymus at different ages (ranging from 2- to 20-






Fig 2-3.  Increased proinflammatory cytokines in the thymus cause lamin-B1 
reduction in TECs upon aging. (A) FACS gating strategy for sorting thymic 
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macrophage. Plot shows frequency of macrophage within gated total live cells. (B) qRT-
PCR analyses of TNF-, IL-1, IL-1 and IL-6 in macrophage in different age stage 
thymuses. Expression is plotted relative to 2-month-old thymus. (C) FACS gating 
strategy for sorting thymic sirp+ DCs and sirp- DC subsets. (D) qRT-PCR analyses of 
TNF-, IL-1, IL-1 and IL-6 in sirp
+
 DCs (left) and sirp
-
 DC (right) subsets in 
different stage thymuses. (E) Western blotting analyses of TNF-, IL-1, IL-1 and IL-6 
in macrophage (left) and sirp
+
 DCs (right) in different age stage thymuses. (F) Western 
blotting analyses of lamin-B1 and lamin-A/C in cultured TECs treated with indicated 
proinflammatory cytokines. All data shown are representative of at least 3 independent 
experiments. Error bars indicate SEM from 3 independent experiments. Student’s t test: *, 
















 DC subsets (Fig. 2-3C and D). I then used quantitative RT-PCR (qRT-PCR) to 
assess the mRNA levels of 4 key pro-inflammatory cytokines, including TNF-, IL-1, 
IL-1 and IL-6, that have been implicated in inflammation-induced thymic degeneration 
(Billard et al., 2011; Gruver and Sempowski, 2008; Sempowski et al., 2000; Youm et al., 
2012). I observed that all these pro-inflammatory cytokines exhibited age-related increase 
in macrophage (Fig. 2-3B) and sirp
+
 DC subset (Fig. 2-3D left) beginning at 6 months, 
while the increase in sirp
-
 DC subset was relatively mild (Fig. 2-3D right; < 3 fold 
change even in 20-month-old thymus). This is consistent with the published microarray 
results (Ki et al., 2014), which showed an augmented inflammatory signature as early as 
6-month, a time lamin-B1 reduction became significant in mTECs and cTECs (Fig. 2-2E).  
Next, I analyzed the protein level of these pro-inflammatory cytokines by Western 
blotting as mRNA level does not always reflect protein level due to post-transcriptional 
regulation. Another reason I have to confirm protein level of these pro-inflammatory 
cytokines by Western blotting is that some precursor species of cytokines, such as IL-1, 
have to be processed into mature form to exhibit inflammatory activity and qRT-PCR 
analysis cannot distinguish precursor from mature species. Western blotting analyses 
showed an age-associated increase in active TNF-, IL-1, IL-1 and IL-6 in both 
macrophage and sirp
+
 DC (Fig. 2-3E). These analyses suggest that the proinflammatory 
cytokines secreted from macrophage and sirp
+
 DC could contribute, at least in part, to 
an inflammatory microenvironment within the thymus upon aging.  
To explore the effect of these proinflammatory cytokines on lamin-B1 in TECs, I 
established an in vitro primary TEC culture system (Jain and Gray, 2014). Upon 
treatment with TNF- (10 ng/ml), IL-1 (20 ng/ml) and IL-6 (20 ng/ml), I observed a 
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significant reduction of lamin-B1, but not lamin-A/C, in cultured TECs within 5-day 
treatment (Fig. 2-3F). In contrast, IL-1 (20 ng/ml) treatment did not cause a clear lamin-
B1 reduction as seen in the other 3 cytokines. Additionaly, I also found that treatment 
with G-CSF (20 ng/ml), which was among the top 5 up-regulated intrathymic cytokines 
in inflammation-induced thymic involution model (Billard et al., 2011), did not lead to 
lamin-B1 reduction under the same condition, suggesting that lamin-B1 reduction in 
TECs could be induced by selected cytokines.  
 
Proinflammatory cytokines can induce lamin-B1 reduction in TECs via senescence 
To address the mechanism underlying proinflammatory cytokine-induced lamin-
B1 reduction in TECs, I decided to first assess whether TECs undergo apoptosis upon 
cytokine treatment. Caspase activation by apoptotic signals has been shown to result in 
cleavage of nuclear lamins (Cuvillier et al., 1998; Fraser et al., 1997; Ruchaud et al., 
2002; Takahashi et al., 1996). I examined the presence of 39 or 37 kD cleaved caspase 9, 
which marks initiation of the apoptotic process, in TECs treated with indicated cytokines 
for 120 hours (Fig. 2-4A). I did not detect obvious cleaved bands of active caspase 9 even 
after long-time exposure, suggesting that lamin-B1 reduction is not triggered by apoptosis. 
To further confirm this, I performed FACS analysis for two apoptotic markers Annexin V 
and 7-AAD in TECs treated with indicated cytokines for 120 hours and then quantified 




apoptotic cells (Fig. 2-4B). The FACS results 




Fig 2-4. Proinflammatory cytokines can cause lamin-B1 reduction in cultured TECs 
via senescence. (A) Western blotting analysis reveals no apparent apoptosis in in vitro 
cultured TECs upon inflammatory cytokine treatment. Arrow (top) indicates 49 kD 
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procaspase 9; two arrows (bottom) indicate the predicated locations of 39 kD and 37 kD 
cleaved activated caspase 9. (B) FACS analyses of Annexin V and 7-AAD reveal no 
significant apoptosis between control and inflammatory cytokine groups. Left: 
representative FACS plots of Annexin V and 7-AAD staining of TECs; Right: 
quantification of apoptotic cells. (C) Increased senescence in TNF-a, IL-1 and IL-6 
treated TECs as judged by -galactosidase staining. Scale bars, 20 m. (D) Percentage of 
-galactosidase positive cells. Total 150 cells from 3 biological replicates were counted 
from each experimental group for quantification. (E) qRT-PCR analyses of p21 and p16 
reveal different signaling pathways involved in proinflammatory cytokine-induced 
senescence in TECs. All data shown are representative of at least 3 independent 
experiments. Error bars indicate SEM from 3 independent experiments. Student’s t test: *, 













apoptosis compared to untreated cells as less than 10% of TECs exhibited either Annexin 
V or 7-AAD positive signal (Fig. 2-4B right).  
In addition to apoptosis, lamin-B1 loss is commonly observed in cells undergoing 
senescence (Freund et al., 2012).  By assessing -galactosidase activity, a known marker 
of senescence (Dimri et al., 1995; Itahana et al., 2007), I observed that 40-65% of TECs 
were positive for -galactosidase staining after treating with TNF-, IL-1 and IL-6 for 
120 hours. By contrast, -galactosidase activity was rarely detected in IL-1 and G-CSF 
groups (Fig. 2-4C and D). Senescence growth arrest is established via either p53 or p16-
retinoblastoma protein (pRB) tumor suppressor pathway (Campisi and d'Adda di Fagagna, 
2007). Due to a small number of TECs and low amount of total protein extracted from in 
vitro cultured TECs, it is not possible to assess phosphorylation of p53 and RB.  Thus, I 
decided to use qRT-PCR assay to measure mRNA levels of p21 and p16, two key cyclin-
dependent kinase inhibitors involved in p53 and pRB mediated senescence, respectively. 
I found that TNF- induced a strong up-regulation of p21 expression in TECs while IL-
1 and IL-6 mainly engaged in the p16-pRB signaling pathway (Fig. 2-4E). Together, 
these data suggested that proinflammatory cytokines could trigger lamin-B1 reduction in 
TECs at least in part by inducing senescence growth arrest. 
 
Lamin-B1 reduction in TECs in thymus undergoing inflammation-mediated acute 
involution 
Above studies suggest that age-associated elevation of inflammation in the 
thymus could contribute to lamin-B1 reduction in TECs. To further explore the 
physiopathological relevance of inflammation-induced lamin-B1 reduction in vivo, I 
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established an acute endotoxin-induced thymic involution model, which is characterized 
by inflammatory response with significantly elevated intrathymic expression of TNF- 
(2.6 fold), IL-1 (3.5 fold) and IL-6 (37.5 fold, Top2) (Billard et al., 2011; Gruver and 
Sempowski, 2008; Sempowski et al., 2002). I examined whether lamin-B1 reduction in 
TECs occurred during inflammation-mediated thymic degeneration. 2-month-old female 
C57BL/6 mice were intraperitoneally (IP) injected once with Escherichia coli-derived 
lipopolysaccharide (LPS, 100 µg) or saline to induce thymic involution. Consistent with 
published data, total thymic cellularity as measured by cell number counts was 
significantly decreased 48 hours post induction (Fig. 2-5A left). FACS analysis of the 
CD4 and CD8 expression patterns revealed that distribution of thymocyte subsets was 




 DP cells within 48 hours post 
challenge (Fig. 2-5A right). An early study carried out transcriptome analysis of whole 
thymus tissue by microarray during the early stage of this acute thymic atrophy (Billard 
et al., 2011). Given that thymocytes comprise more than 95% of the total cellularity of 
the thymus, the previous transcriptome profiling should only reflect the effects of acute 
inflammation on thymoyctes but not on TECs. To uncover the impact of acute 
inflammation on TECs in vivo, I applied FACS sorting to isolate mTECs 48 hours post 
LPS challenge and then performed whole genome-wide transcriptional profiling using 
RNA-seq (data not shown). Due to insufficient cell number of isolated cTECs, only 
mTECs were used for this experiment. Interestingly, by analyzing transcriptional changes 
of major components of the nuclear lamina (NL), I found that lamin-B1, but not other 




Fig 2-5. Inflammation leads to lamin-B1 reduction in TECs in vivo in the endotoxin-
induced acute thymic involution model. (A) Total cell number of thymus at the 
indicated times after one-dose LPS (100 g) challenge (left); Representative FACS plots 
of CD4 and CD8 staining in thymocytes from 2 independent experiments at 48 hours post 
LPS treatment (right). (B) RNA-seq analyses reveal selected up- and down-regulated 
genes in components of the nuclear lamina in mTECs in endotoxin-induced acute thymic 
atrophy model. (C) Western blotting analyses reveal a significant reduction of lamin-B1 
but not lamin-A/C in mTECs in endotoxin-induced acute thymic atrophy model. β-actin 
is used as a loading control. Error bars indicate SEM from at least 3 independent 
experiments. Student’s t test: *, P < 0.05; **, P < 0.01; ***, P < 0.001; ns, not significant. 
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atrophy (Fig. 2-5B). Using Western blotting assay, I further confirmed that more than 
70% reduction of lamin-B1 in mTECs at the protein level (Fig. 2-5C), suggesting that 
lamin-B1 may be more sensitive to an inflammatory challenge than other NL components.  
 
Discussion 
Application of flow cytometry to analyze nuclear lamins 
While flow cytometry is commonly used in the immune field with a wide variety 
of applications, to the best of my knowledge, it has not been applied to the study of 
nuclear lamins. Using the thymus as an example, I have demonstrated that flow 
cytometry is indeed a quick and effective tool for quantifying nuclear lamins in cells 
directly isolated from tissues in vivo. The approach I have introduced has two major 
advantages. First, by labeling with cell-type specific marker(s), this new method allows 
me to simultaneously measure lamins in different cell types from the same sample, which 
makes it possible to perform systematic screening of lamin loss in a mammalian 
tissue/organ. In the thymus study, I applied this approach to measure nuclear lamins in 
almost all the known cell types in this organ, including thymocytes from different 
developmental stages, macrophage, DC, fibroblast and TECs. It is very difficult, if not 
impossible, to do this kind of study using conventional methods such as Western blotting 
or IF. This flow cytometry-based method can be readily adapted for other tissues/organs. 
For example, our lab recently reported a gradual reduction of lamin-B in the brain of the 
aged fly based on Western blotting analysis (Tran et al., 2016). This finding raises one 
interesting hypothesis that loss of lamin-B may contribute to dysfunction and aging of the 
brain. It is not clear if this finding is reflective of a natural physiological change in the 
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brain or whether it might be involved in some disease conditions, such as Alzheimer. To 
explore this hypothesis, it is possible to apply this new method to quantify lamin protein 
levels in young and aged mouse brains. By labeling different fluorochrome dyes with 
specific antibodies recognizing four major cell types present in the vertebrate brain, 
including Neuna60 (neuron), GFAP (astrocyte), IBA1 (microglia) and Oligo1/2 
(oligodendrocyte), it would allow one to assess whether and/or which cell type(s) 
undergoes lamin reduction upon aging. 
Another virtue of the new method is the quantitative measurement of nuclear 
lamins based on the mean fluorescence intensity (MFI) of lamin signals from flow 
cytometry data (Fig. 2-2A). I have shown that the extent of lamin-B1 reduction in both 
mTECs and cTECs is well correlated with the progressive decline of total cellularity in 
the thymus upon aging (Fig. 2-2E), indicating that lamin-B1 may contribute to thymic 
degeneration. This finding is consistent with our previous study showing that lamin-B 
loss leads to tissue dysfunction in fly fat body (Chen et al., 2014), suggesting that lamin-
B may play an evolutionary conserved role in tissue maintenance and its reduction 
contributes to age-associated tissue dysfunction.  
The method will also allow one to more accurately reevaluate the level of other 
proteins, such as Foxn1 (Chen et al., 2009) and Ghrelin (Dixit et al., 2007; Taub et al., 
2010; Youm et al., 2009), whose age-associated reduction has been previously proposed 
to contribute to thymic involution by some studies but refuted by others (Chen et al., 
2009; Ki et al., 2014; O'Neill et al., 2016; Ortman et al., 2002; Sun et al., 2010). The 
ability to accurately measure the levels of these poteins in TECs during aging should help 
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to clarify the confusion regarding whether the reduction of any proteins in TECs or other 
cells in the thymus contributes to its involution. 
 
Identification of age-associated lamin-B1 reduction in thymic epithelial cells 
The human skin is reported to naturally exhibit an age-related loss of lamin-B1 in 
mammalian (Dreesen et al., 2013a; Dreesen et al., 2013b). Unfortunately, our 
unpublished studies did not find lamin-B1 reduciton in the skin of eyelids from elderly 
individuals. It still remains unclear the physiological impact of lamin-B1 loss on the 
aging process of the skin as deletion of both Lmnb1 and Lmnb2 in keratinocytes did not 
cause overt abnormalities in the skin and hair, even in 24-month-old mice (Yang et al., 
2011). Interestingly, a recent study reported a reduction of lamin-B1 protein and a 
disruption of the nuclear lamina in neurons in the brain from Alzheimer’s patients, 
indicating that lamin dysfunction may mediate neurodegenerative disorders (Frost et al., 
2016).  In this study, I reported the third case in mammals showing a specific reduction of 
lamin-B1 but not lamin-B2 and –A/C in TECs in the aged thymus. Consistent with our 
previous finding that not all old tissues lose lamin-B in aged fly, I did not detect any 
apparent change of lamin-B1 in other cell types such as thymocytes and HSC-derived 
myeloid lineage cells in the aged mouse thymus (data not shown). My findings raise an 
interesting question as to why different cell types exhibit differential regulation of lamin-
B1 in the same microenvironment context. One possibility is that age-related changes in 
the thymic environment have distinct impacts on individual cell types and only TECs are 
sensitive to such environmental changes in the context of lamin-B1 reduction. For 
example, while IL-6 has been reported as a costimulatory molecule for T cell activation 
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and proliferation, my results suggests that IL-6 might induce cellular senescence of TECs 
and senescence-associated lamin-B1 reduction (Fig. 2-3 and 2-4). Age-associated lamin-
B loss has been demonstrated to lead to heterochromatin loss and derepression of 
inflammatory genes (Chen et al., 2014). Since all vertebrate cells express at least one 
lamin protein and lamins may share some conserved functions across different species 
(Dechat et al., 2010), my finding indicates that loss of lamin-B1 in TECs may lead to 
derepression of inflammatory genes and in turn may result in intrathymic inflammation in 
aged thymus, which are known to play a critical role in driving the late stage thymic 
involution (Chinn et al., 2012; Sempowski et al., 2000). The whole genome-wide 
transcriptiome analyses of TECs from Lmnb1 mutant and aged mouse thymuses will be 
studied to further explore the underlying mechanism and I will discuss them in Chapter 4.  
 
Proinflammatory cytokines, lamin-B1 reduction and senescence 
Proinflammatory cytokines such as TNF and IL-6 have been implicated to play 
dual roles in the thymus. Physiologically optimal levels of these cytokines are essential 
for early T-cell development. For example, TNF-mediated activation of NF-b 
promotes the survival and development of single positive T cells in the thymus (Webb et 
al., 2016). Thymic differentiation of Interleukin 17 (IL-17)-producing CD4
+
 T cell also 
depends upon the basal level of IL-6 (Marks et al., 2009). On the other hand, the age-
associated abnormal increase of intrathymic proinflammatory cytokines is known to play 
a key role in exacerbating the late stage thymic degeneration. In my study, I confirmed 
that thymic macrophages and sirp
+
 DC acquired a proinflammatory signature during the 
early stage of involution (~6-month-old thymus, Fig. 2-3) (Ki et al., 2014). and further 
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increase of these cytokines correlated with the progression of thymic degeneration (Fig. 
2-2 and 2-3), suggesting that they may function as an initial trigger of age-associated 
thymic involution. Consistent with this, a recent transcriptional profiling study revealed 
that up-regulation of proinflammatory genes in thymic sirp
+
 DC is a key hallmark 
during the early thymic involution (Ki et al., 2014). How increased expression of 
inflammatory cytokines leads to thymic degeneration is not well understood. I showed 
that some of the elevated proinflammatory cytokines (TNFa, IL-1 and IL-6) induced 
lamin-B1 reduction in cultured TECs in vitro (Fig. 2-3F) and also found that lamin-B1 
reduction in inflammation-induced thymic atrophy model in vivo (Fig. 2-5), indicating 
lamin-B1 as a common downstream target for these cytokine-mediated alterations in 
TECs. In addition, I demonstrated that proinflammatory cytokines could trigger lamin-B1 
reduction in TECs at least in part via inducing senescence (Fig. 2-4). Interestingly, 
different proinflammatory cytokines engage in distinct pathways to induce TEC 
senescence. TNF--induced senescence in TECs appears to be mediated through the p53-
p21 pathway, while IL-1 and IL-6 mainly engaged in the p16-RB signaling pathway 
(Fig. 2-4D). In agreement with my finding, increased senescence in thymic TECs was 
identified as one of hallmarks upon aging and contributed to architectural and 
morphological changes in aged mouse thymus (Aw et al., 2008). It has been reported that 
senescence of mammalian fibroblast is associated with lamin-B1 loss and increased 
secretion of inflammatory cytokine (referred to as senescence-associated secretory 
phenotype, SASP) and lamin-B1 depletion in proliferating cells can also trigger 
senescence (Coppe et al., 2008; Freund et al., 2012; Salama et al., 2014; Shah et al., 
2013). Thus, age-associated reduction of lamin-B1 in TECs may contribute to the 
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abnormal increase of intrathymic inflammatory cytokines in aged thymus, which further 
accelerates degenerative process. I will dissect the role of lamin-B1 in TECs for thymic 
aging in Chapter 3.  
 
Materials and methods 
Mice  
All mouse experiments were approved by the Institutional Animal Care and Use 
committee of Carnegie Institution for Science. 20-month-old female C57BL/6 mice were 
purchased from National Institution on Aging. Other mice in cohort experiments at the 
indicated ages were raised by the mouse facility of Carnegie Institution for Science. All 
animals were housed in specific pathogen-free conditions under a 12/12hour light dark 
cycle and fed ad libitum. 
 
Endotoxin-induced thymic involution model 
The procedure follows a detailed protocol described in (Billard et al., 2011). In brief, 
Escherichia coli-derived lipopolysaccharide (LPS, Sigma-Aldrich L-2880) was 
reconstituted at 1 mg/mL in PBS. 2-month-old female C57BL/6 mice were injected once 
intraperitoneally with LPS (100 µg) or saline to induce thymic involution. Thymuses 
were collected at indicated time points for phenotype analyses and lamin measurement. 
 
Primary TEC isolation and culture 
 
TECs were prepared according to a published protocol with modifications (Jain and Gray, 
2014). In brief, fat and connective tissue were first removed from thymic lobes. Thymic 
lobes were cut into 2 mm pieces and then treated for 15 min at 37 °C with an enzymatic 
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mixture containing 0.25 U Liberase TM (Roche) and 0.1% DNase I (Sigma-Aldrich) in 
RPMI 1640. The supernatant was collected, and the digestion was repeated twice. Cells 
were filtered through 100μm cell strainer and spun at 1200 rpm for 5 min. The CD45
+
 
cells were depleted by CD45 microbeads (Miltenyi Biotec 130-052-301) and enriched 
CD45- cells were then stained with DAPI, CD45, EpCAM, Ly51, I-A/I-E (Biolegend) 
and UEA-1 (Vector laboratories) for 20 min at 4°C followed by sorting with 
FACSAria
TM






















FACS sorted TECs were further subjected to either downstream analyses or culture. For 
primary TEC culture, ~50,000 TECs were seeded in 48-well culture plates and cultured 
for up to 7 days in Dulbecco's modified Eagle's medium nutrient F12 (Invitrogen) 
supplemented with 3 μg/ml insulin (Sigma-Aldrich), 20 ng/ml epidermal growth factor 
(PeproTech), 100 units/ml penicillin-streptomycin, and 10% fetal bovine serum. Cultures 
were maintained at 37 °C and 5% CO2, and the medium was changed every two days. 
For pro-inflammatory cytokine treatment, TECs were cultured with above-mentioned 
medium supplemented with different concentrations of cytokines (10 ng/ml TNF-, 
PeproTech; 20 ng/ml IL-1, Biolegend; 20 ng/ml IL-6, PeproTech; 20 ng/ml in IL-1, 
Biolegend; 20 ng/ml G-CSF PeproTech), TECs were collected at indicated time points 
for RNA or protein extraction. 
 
Flow cytometry analysis of nuclear lamins 
Single-cell suspension of freshly dissected thymus was prepared as described for TEC 
isolation without depletion of CD45
+
 cells. Cells were first treated with TruStain fcX kit 
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(Biolegend) to block CD16/32 and Zombie UV™ fixable viability kit to exclude dead 
cells before cell surface marker staining. Surface marker staining was used to distinguish 
different cell types within the thymus: CD4/CD8 (T cell subsets); CD11c (DC); F4/80 















. After surface 
marker labeling, staining of lamins follows the detailed protocol described in the True-
Nuclear Trascription Factor kit (Biolegend).  I use an Alexa Fluro 647 antibody labeling 
kit (Life technology) to prepare fluorochrome-conjugated lamin antibody. In brief, 50μg 
rabbit anti-lamin-B1 (Abcam), mouse anti-lamin-B2 (Invitrogen, E3), mouse anti-lamin-
A/C (Active Motif) and control rabbit or mouse IgG (Santa Cruz) was labeled following 
the manufacturer’s protocol. Fluorochrome-conjugated antibodies were reconstituted at 
0.5 mg/mL in PBS and 0.1 μg of each antibody was used for staining 10
6
 cells in 100μl 
volume. All samples were stained for 20 min at 4°C if not specifically indicated and then 
were immediately processed for FACS analyses by FACSAriaTM III (BD Bioscience). 
Data was analyzed with FlowJo software (Tree Star). All FACS antibodies were 
purchased from Biolegend if not indicated. 
 
Flow cytometry analysis and sorting  
Single-cell suspension of the thymus was prepared by passing minced tissue through a 
40μm cell strainer. Cells were treated with TruStain fcX kit (Biolegend) to block 
CD16/32 before staining. All surface markers were stained for 20 min at 4°C, if not 
specifically indicated, and then were immediately processed for FACS analyses or sorting 
by FACSAriaTM III (BD Bioscience). FACS antibodies used for experiments include: 
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Thymocyte: CD4, CD8; macrophage: F4/80, CD11b; DC subsets: CD11c, EpCAM, 
CD80, I-A/I-E, Sirpα. Macrophage and DC sebsets were directly sorted into Trizol (Life 
technology) for RNA or Laemmli sample buffer (Bio-rad) for protein extraction. FITC 
Annexin V Apoptosis Detection kit with 7-AAD (BioLegend) was used to detect 




mESCs stained with Alexa647-conjugated anti-lamin-B1 antibody were collected by 
FACS sorting and then attached to glass slides by cytospin (Shandon Cytospin 4) spun at 
1200 rpm for 5 min. Attached mESCs were stained with DAPI and mounted with 
ProLong® Gold Antifade Mountant (Fisher Scientific). Confocal images were acquired 
using a laser-scanning confocal microscope (Leica SP5) with a 63X/1.4 objective. Images 
were processed using ImageJ.  
 
 
Western blotting analysis 
Whole-cell lysates were generated using Laemmli sample buffer (Bio-rad) and diluted in 
SDS-PAGE sample buffer. Cell lysates were separated in 10% or 15% SDS-PAGE and 
then transferred onto nitrocellulose membranes. The membranes were blocked with 5% 
milk and probed with the following antibodies: rabbit anti-lamin-B1 (1:5000, Abcam), 
mouse anti-lamin-A/C (1:5000, Active Motif), rabbit anti-TNF- (1:1000, Cell 
Signaling), rabbit anti-IL-1 (1:1000, Cell Signaling), rabbit anti-IL-6 (1:1000, Novus 
biological), rabbit anti-IL-1 (1:2000, Santa cruz), mouse anti-caspase9 (1:1000, Cell 
Signaling) or mouse anti-β-actin (1:4000, Sigma, AC-15). Antibodies were detected with 
HRP-conjugated anti-mouse (1:10000) or anti-rabbit (1:10000) antibodies and West Pico 
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Substrate (Thermo Scientific). 
 
Senescence-associated (SA)-β-gal assay 
Senescence β-Galactosidase Staining kit (Cell Signaling, 9860S) was used to detect β-
galactosidase activity at pH 6.0. In brief, in vitro cultured TEC cells were fixed in the 
fixative solution for 10 min at room temperature. The fixed cells were washed twice with 
PBS and then incubated with β-galactosidase staining solution containing X-gal at 37°C 
overnight. As the blue color developed, bright-field cell images were taken using an 
Axiovert 25 microscope (Carl Zeiss) connected to a Canon camera. Total 150 cells from 
3 biological replicates were counted from each exprimental group for quantification. 
 
RNA preparation and quantitative real-time PCR 
TECs were isolated and enriched as described above. Total RNA was extracted following 
the manufacturer’s protocol of Direct-zol™ RNA MicroPrep kit (Zymo Research R2060). 
Quantitative RT-PCR was performed using the iScript One Step RT-PCR kit (170-8892; 
Bio-Rad Laboratories) on a real-time PCR detection system (CFX96; Bio-Rad 
Laboratories). 50 ng of total RNA was reverse transcribed and amplified as follows: 50°C 
for 10 min, 95°C for 5 min, 95°C for 10 s, 60°C for 30 s, 72°C for 1 min. Steps 2–4 were 
repeated for 40 cycles. Each reaction was performed in triplicate, and the results of three 
independent experiments were used for statistical analysis. Relative mRNA expression 
levels were quantified using the ΔΔC (t) method (Pfaffl, 2001). Results were normalized 
to those for GAPDH, and primer sequences were listed as follows.  
TNF-: forward primer (F): CTGTAGCCCACGTCGTAGC;  
Reverse primer (R): TTGAGA TCCATGCCGTTG.  
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IL-1: F: TGTAATGAAAGACGGCACACC; R: TCTTCTTTGGGTATTGCTTGG.  
IL-1: F: CCGAGT TTCATTGCCTCTTT; R: ACTGTGGGAGTGGAGTGCTT.  
IL-6: F: CTCTGGGAAATCGTGGAAAT; R: CCAGTTTGG TAGCATCCATC.  
P21: F: GACAAGAGGCCCAGTACTTC; R: GCTTGGAGTGATAGAAATCTGTC. 
P16: F: CGTACCCCG ATTCAGGTGAT; R: TTGAGCAGAAGAGCTGCTACGT. 
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Emerging evidence suggests that nuclear lamins, the type V intermediate filament 
proteins, play an important role linking aging-related inflammation to tissue 
homeostasis/aging.  As described in Chapter 2, I have uncovered an age-associated 
lamin-B1 reduction in TECs, which correlates with the progression of age-related thymic 
involution. In this chapter, I investigate the potential function of lamin-B1 in TECs using 
a variety of mouse genetic models. I show that TEC-specific deletion of Lmnb1, but not 
Lmnb2 or Lmna, leads to thymic atrophy and a number of changes in the TEC 
compartment that are remarkably similar to reported age-related defects. Additionally, I 
show that lamin-B1 deficiency in TECs accelerates age-associated thymic adiposity, at 
least in part via dampening the ghrelin receptor-mediated signaling in mTECs. By using 
different combinations of transgenic T cell receptor (TCR) mouse models, I further 
demonstrate that lamin-B1 is required for proper antigen presentation in TECs and that 
lamin-B1 deficiency in TECs leads to inefficient positive and negative selection of T 











The previous studies of nuclear lamins in different model organisms clearly 
demonstrated that B-type lamins are required for proper organogenesis of multiple but 
not all tissues/organs (Chen and Zheng, 2014; Frost et al., 2016; Kim et al., 2011). The 
mechanisms underlying lamin-mediated differential effects in different organs are still 
not well understood. In contrast to extensive studies on the role of lamins in development, 
the role of B-type lamins in tissue/organ homeostasis and aging remains largely 
unexplored. By studying the Drosophila immune organ, called fat body, our lab 
uncovered a mechanism by which lamin-B reduction in the cells of fat body upon aging 
induced age-associated systemic inflammation and tissue damage, suggesting that lamin-
B plays a critical role in tissue homeostasis/aging and immunosenescence (Chen et al., 
2014). The physiological significance of this finding needs to be further assessed in other 
tissue/organ(s) in vivo especially in the context of mammalian aging. In the preceding 
chapter, I reported an age-associated reduction of lamin-B1 but not lamin-B2 and -A/C in 
the TECs in the thymus. The reduction of lamin-B1 correlated with age-related 
progressive degeneration of the thymus, implying a potential role of lamin-B1 in 
contributing to the thymic involution. 
While considerable effort has been focused on mechanisms controlling 
development of the thymic microenvironment essential for T-cell generation, the 
molecular mechanisms that mediate thymic homeostasis and involution are still not well 
understood (Boehm and Swann, 2013). One of the major impediments to studying thymic 
involution is that age-associated transcriptome analysis of TECs has only recently been 
studied during early involution stage (Ki et al., 2014). Therefore, the field has relied 
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almost exclusively on the Foxn1 to explain thymic aging for more than a decade. Whole 
genome-wide transcriptional profiling suggested a role for proinflammatory cytokines in 
initiating thymic degeneration, which was previously thought to participate in late stage 
of involution (Ki et al., 2014). The underlying mechanism by which elevated 
proinflammatory cytokines initiate thymic involution is poorly understood. In the 
previous chapter, my studies suggest an inflammation-mediated nuclear defect, lamin-B1 
reduction in TECs, which in turn appears to be associated with thymic degeneration. Here, 
I describe my investigation of the role of lamin-B1 in TECs using mouse genetic models, 
which leads to the uncovering of several important roles of lamin-B1 in T-cell generation, 




TEC-specific deletion of Lmnb1 causes thymic atrophy        
To address the potential roles of nuclear lamins in TECs, I first deleted individual 






mice with Foxn1-Cre 
(FN1Cre) mouse line (Gordon et al., 2007). Interestingly, while the conditional ablation 
of either Lmnb2 or Lmna in TECs had no obvious effect on the size and total cellularity 
of thymus in 2-month-old mice (Fig 3-1B), depletion of Lmnb1 in TECs resulted in 
apparent thymic atrophy as judged by the significantly reduced size and total cell number 
(~80% to 85% reduction). The degree of this atrophy is comparable to thymuses from 20-
month-old mice (Fig 3-1A). Although Foxn1 is expressed in keratinocytes and hair 
follicles and FN1Cre can induce deletion of the corresponding genes in these cell types 
besides TECs, I note that none of these lamin-depleted mouse lines exhibit any obvious 




Fig 3-1. Depletion of Lmnb1 but not Lmnb2 and Lmna in TECs induces thymic 





;FN1Cre mice and an old (20-month) wild type (WT) control 





, n=7; Lmnb1 mutant, n=7; age, n=3. (B) Ablation of Lmnb2 (left, n=4) and 
Lmna (right, n=4) in TECs do not cause obvious thymic atrophy. Top: representative 
pictures of thymuses; bottom: total cell number counts with indicated genotypes. (C) 
Quantification of total cell numbers in thymuses from mice after depletion of Lmnb1 in 
either mTEC (n=7) or cTEC (n=5) by Tamoxifen (TAM) treatment. 2-month-old mice 
with indicated genotypes were treated with a single intraperitoneal (IP) injection of TAM 
(1mg/10 g body weight/day) for five successive days and with TAM (0.025 mg/ml) kept 
in the drinking water. Thymic phenotypes were analyzed 4 weeks after the 5th TAM 
injection. All data shown are representative of at least 3 independent experiments and are 















on embryonic day 11.5 (E11.5) in TECs, FN1Cre would drive Lmnb1 deletion in TECs 
during embryonic development. To dissect the role of lamin-B1 in the adult mouse 
thymus, I next employed Keratin5- (K5) and Keratin8- (K8) CreER
T2
 systems to induce 
Lmnb1 deletion in either mTEC or cTEC, respectively, in adult thymus following 
tamoxifen (TAM) injection. Preliminary results suggested that one dose of TAM (1mg 
TAM/10g/day, see methods) on five consecutive days resulted in a ~60% reduction of 
Lmnb1 mRNA (data not shown) in both mTEC and cTEC. 4 weeks after the 5th TAM 









mice was reduced by 50-60% compared to the control groups (Fig 3-1C). 
Together, these results suggest that loss of lamin-B1 in TECs in adult thymus accelerates 
thymic degeneration. 
 
Depletion of lamin-B1 in TECs leads to altered thymic epithelial compartments  
           To investigate the cellular basis for thymic atrophy upon lamin-B1 deletion, I first 
used hematoxylin and eosin (H&E) staining to examine the structural organization of the 
thymus. It has been well documented that a progressive disruption of the cortical 
medullary junction region (CMJ) occurs in aged thymus (Aw et al., 2008; Gray et al., 
2006). H&E staining of Lmnb1 mutant thymus revealed a clear blurring of the CMJ (Fig 
3-2A). I next performed keratin immunostaining to examine the distribution and 
architectural organization of cTEC and mTEC compartments. In 2-month-old control 
thymus, K5
+
 mTECs typically form a compact medullary compartment surrounded by 
cortex region composed of K8
+ 
cTECs (Fig 3-2B, top). In contrast, I observed a complete 




Fig 3-2. Lamin-B1 deficiency in TECs leads to altered thymic epithelial 
compartments. (A) Hematoxylin and eosin (H&E) staining of thymic tissue sections 
reveals disorganization of the TEC compartment in Lmnb1 mutant thymus. A 20-month-
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old WT involuted thymus is shown as an aged representative. The cortical medullary 
junction (CMJ) areas marked by white lines are enlarged at the bottom. Arrows indicate 
blurring of the CMJ areas in both aged and Lmnb1 mutant thymuses. (B) Keratin staining 
reveals abnormal mTEC and cTEC organization in Lmnb1 mutant and aged thymuses. A 
white dash line indicates intact medulla region in 2-month-old WT thymus. Green: anti-





) TECs in both aged and Lmnb1 mutant thymuses. White dash lines 




 TECs in the CMJ region in WT 




 TECs in cortical regions in both aged and Lmnb1 
mutant thymuses. Green: anti-keratin8; Red: anti-keratin5. (D) Flow cytometry analysis 








 cTECs within the gated 
EpCAM
+
 TEC population. FACS plots shown are representative of at least 3 independent 
experiments. (E) Quantification of frequency of mTECs and cTECs in WT (n=13), 
Lmnb1 mutant (n=7) and aged (n=4) thymuses. (F) Quantification of total cell number of 
mTECs and cTECs in WT (n=13), Lmnb1 mutant (n=7) and aged (n=4) thymuses. All 
data shown are representative of at least 3 independent experiments and are plotted as 








islets distributed throughout the whole aged and Lmnb1 mutant thymuses (Fig 3-2B 





) TECs present in both aged and Lmnb1 mutant thymuses 




TEC subset was found in the early embryonic thymus between 
E12.5-15.5 and was proposed as a bipotent TEC progenitor that gave rise to either mTEC 
or cTEC (Klug et al., 1998). This finding promoted me to further explore the alteration of 
TEC cellular composition in the Lmnb1 mutant thymus.  
TECs isolated from 2-month-old Lmnb1
f/f
;FN1Cre mutant thymuses and control 
littermates were further analyzed by flow cytometry. Consistent with published results, 






) were the predominant subset 




) in the young WT thymus (Fig 3-2D left). 
However, in both aged and Lmnb1 mutant thymuses, I observed a pronounced decrease 
of mTEC population, with a skew towards a cTEC dominant stromal compartment (Fig 







) that does not express canonical surface markers for either 
mTEC or cTEC in both aged and Lmnb1 mutant thymuses (Fig 3-2D, marked within blue 





TEC subset detected in IF assay (Fig 3-2C) and additional 
transcriptome analysis will be needed to characterize the identity of this DN-TEC 
subpopulation. Furthermore, lamin-B1 deficiency in TECs led to a significant reduction 
in the number of mTECs but not cTECs, which is similar to the trend for mTECs 




Loss of lamin-B1 in TECs accelerates age-related thymic adiposity 
One of the hallmark changes associated with age-associated thymic involution is 
the gradual replacement of the TEC compartment with adipose tissue (Dixit, 2010). 
Lineage tracing data reveal that adipose cells are of intrathymic origin and are derived 
from Foxn1
+
 TECs via epithelial-to-mesenchymal transition (EMT) (Youm et al., 2009). 
In previous experiments, I observed a notable increase of perithymus fat tissue (data not 
shown) in the 2-month-old Lmnb1 mutant thymus, which led me to further investigate 
whether or not loss of lamin-B1 in TECs promoted thymic adipogenesis. I performed a 
longitudinal analyses of thymic adiposity in mice up to 12-month of age and found a 
remarked accumulation of adipose tissue surrounding the 6- to 8-month-old Lmnb1 
mutant thymus (Fig 3-3A). Oil red staining revealed that fat cells and/or lipid-containing 
cells were abundant in both perithymic and intrathymic regions in Lmnb1 mutant and 
aged thymus compared to the controls (Fig 3-3B). I further used neutral lipid staining to 
confirm the prevalence of lipid-containing cells in Lmnb1 mutant thymus, which 
appeared more severe than that in 20-month-old aged thymus (Fig 3-3C). Recent studies 
demonstrate that the expression of Ghrelin receptor (growth hormone secretagogue 
receptor, or GHSR) in mTECs declines upon aging and deficiency in GHSR-mediated 
signaling facilitates the EMT process and thymic adipogenesis with aging (Yang et al., 
2007; Youm et al., 2009). Therefore, I next measured the mRNA level of GHSR in 
mTECs using qRT-PCR. In agreement with previous studies, I observed a ~50% 
reduction in the expression of GHSR in mTECs isolated from 20-month-old aged thymus 
and ~65% to 70% reduction of this transcript in Lmnb1 mutant thymus compared to the 






Fig 3-3.  Deletion of Lmnb1 in TECs accelerates age-related thymic adiposity. (A) 





;FN1Cre mice. A 20-month-old WT thymus is shown as an aged control. Dash 
line marks the thymus and arrows indicate perithymic fat tissues. Scale bar, 1 mm. (B) 
Oil red staining reveals an increased presence of perithymic (arrow) and intrathymic 
(arrowhead) fat cells in Lmnb1 mutant (6-month) and aged WT (20-month) thymus 
compared to the control. Scale bar, 100 m. (C) Neutral lipid staining (Blue) reveals 
increased lipid-containing cells in Lmnb1 mutant and aged thymus. Scale bar, 100 m. 
(D) qRT-PCR analysis of GHSR expression in mTECs from control Lmnb1
f/f
, Lmnb1 
mutant and aged WT thymuses. All data shown are representative of 3 independent 
experiments and are plotted as mean ± SEM. Student’s t test: *, P < 0.05; **, P < 0.01; 














mTECs further confirmed this finding (in Chapter 4, data not shown). Together, these 
results suggested that loss of lamin-B1 in TECs accelerated age-associated thymic 
adiposity, at least in part, through dampening of GHSR-mediated signaling in mTECs.  
 
Lamin-B1 deficiency in TECs impairs normal T cell development 
There are two major T cell lineages in the thymus, T cells and T cells, 
defined by the types of T cell receptors (TCRs) expressed on their surface. Since TECs 
form distinct niche microenvironments supporting each stage of T-cell development, I 
further explored the impact of lamin-B1 loss in TECs on T-cell development. I first 
analyzed the percentage of distinct stages of developing T cells, ranging from the earliest 





SP was significantly reduced by ~50-60%, respectively, in 
Lmnb1 mutant thymus compared to the control littermates (Fig 3-4A and B). Aged 
thymus also exhibited a similar trend but with less severity (~30-40%; Fig 3-4A and B, 
middle) than that in the Lmnb1 mutant. Meanwhile, similar to aged thymus, the Lmnb1 
mutant thymus did not exhibit any obvious alterations in either DN or double-positive 
(DP) T cell populations with a slightly increased percentage of DP subset (Fig 3-4A and 
B), suggesting that lamin-B1 deficiency in TECs might cause a specific developmental 
defect during the DP to SP transition checkpoint. To test whether lamin-B1 loss in TECs 
in adult thymus leads to a similar defective T-cell development, I employed TAM-
induced Lmnb1 ablation in either mTEC (K5CreET
T2
) or cTEC (K8CreER
T2
) in 2-month-









Fig 3-4. Lamin-B1 is required for TECs to support proper T cell development. 





;FN1Cre thymus. A 20-month-old thymus is 
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included as an aged control. (B) Quantification of frequency of the indicated T-cell 
subsets described in (A). WT, n=7; Lmnb1 mutant, n=6; Age, n=3. (C) & (D) Flow 





SP upon Lmnb1 depletion in mTECs by K5CreER
T2
 (C, n=7) or cTEC by 
K8CreER
T2
 (D, n=5) after TAM injection. Left: representative FACS dot plots; Right: 




SP cells within gated live cells in the 
thymus. (E) Flow cytometry analysis of TCR and TCR expression (left) and 





;FN1Cre thymus (n=3). All data shown are representative of at least 3 
independent experiments and are shown as mean ± SEM. Student’s t test: *, P < 0.05; **, 














confirming that lamin-B1 plays an important role in TECs to support normal 
thymopoiesis.  
T cell is another T-cell lineage arising from the early DN stage and further 
differentiates into effectors such as IFN-producing T1 and IL-17-producing T17 
cells within the thymus (Bonneville et al., 2010; Fahl et al., 2014). They express a more 
restricted TCR repertoire and function like innate immune cells, especially in the gut-
associated immune system. Unlike T cells, the development of T cells in the thymus 
is independent of MHC-mediated antigen presentation by TECs (Chien et al., 2014). I 
observed a similar percentage of T cells in both Lmnb1 mutant and the littermate 
control thymus (Fig 3-4E), indicating that T cell generation is not dependent on lamin-
B1 in TECs.  
In order to further dissect which developmental stage(s) during T cell 
development is specially affected by lamin-B1, I subdivided thymocytes into four 
developmental stages based on the surface expression of TCR chain and CD69 (Johnson 
et al., 2009; Lesourne et al., 2009). Consistent with my previous findings, I did not detect 









(data not shown), which represent immature DN and DP subsets prior to positive 
selection, respectively. Instead, I found that the TEC-specific Lmnb1 mutant thymus had 




population, which represents 
thymocytes completing positive selection (Fig 3-5A and B, shown in black box). The 





(Fig 3-5A middle; Fig 3-5B, left). Collectively, these findings strongly suggest that 





Fig 3-5. Lamin-B1 deficiency in TECs results in defective positive and negative 
selection. (A) Flow cytometry analysis of TCRβ and CD69 expression of thymocyte 


















populations (right). WT, n=6; Lmnb1 mutant, n=5; Age, n=3. (C) Flow 
cytometry analysis of CD4 and CD8 expression reveals a reduction of CD4
+ 
SP upon 
Lmnb1 depletion in OT-II transgenic TCR model. Left: representative FACS dot plots; 
right: quantification of frequency of CD4SP within OT-II transgenic TCR thymocytes 
(n=5). (D) Flow cytometry analysis reveals a significant reduction of CD4
+ 
SP induced 
by OVA-mediated deletion in both control and Lmnb1 mutant thymus (left); 
quantification of OVA-mediated deletion efficiency of CD4
+ 
SP in control and Lmnb1 
mutant thymus (right, n=3). (E) Flow cytometry analysis of surface expression of OT-II 
transgenic TCRβ V5.1 on CD4
+
 T cells from the spleen. The left histogram shows the 
frequency of TCRβ V5.1
high
 population in the spleen of control Lmnb1
f/f
;OTII (n=3); The 
right histogram overlay shows the frequency of TCRβ V5.1
high
 population in the spleen of 
control Lmnb1
f/f
;OTII;OVA (black, n=4) and Lmnb1
f/f
;OTII;OVA;FN1Cre mice (red, 
n=3). All data shown are representative of at least 3 independent experiments and are 







altered positive selection. In addition, the Lmnb1 mutant thymus also exhibited a marked 




population (Fig 3-5A, shown in red 
box; Fig 3-5B, right), implying either enhanced negative selection or a defective final 
maturation process caused by lamin-B1 deficiency in mTECs in the medulla region.  
Developmental defects in T-cell selection can be assessed in mouse genetic 
models bearing different transgenic TCRs. Among these, the OT-II is a MHC class II-
restricted TCR-transgenic mouse allele commonly used to examine positive selection. 
When DP cells express the OT-II transgenic TCR, ~50% of DP cells are preferentially 
induced towards CD4
+ 
SP cells (Fig 3-5C left), thus facilitating quantitative analysis of 
defects in positive selection. In the thymus of Lmnb1
f/f
; OT-II; FN1Cre mouse, I found a 
substantial reduction of transgenic CD4
+ 
SP cells (Fig 3-4C), demonstrating that lamin-
B1 plays an important role in cTEC-mediated positive selection. It is noteworthy that the 
FN1Cre was only expressed in ~75-80% TECs based on results from a reporter allele 
(Gordon et al., 2007), indicating that ~20-25% of TECs escape Cre-mediated gene 
deletion. I would expect more severe defects in positive selection if Lmnb1 were 
completely depleted in cTECs. The milder phenotype may be due to the residual WT 
TECs, which can ameliorate the defects.  
I next turned to the RIP-mOVA model to assess whether lamin-B1 deficiency in 





 SP cells. The RIP-mOVA allele uses the rat insulin 
promoter to drive the expression of chicken ovalbumin (OVA), an antigen recognized by 
OVA-specific OT-II TCRs, in mTECs and preferentially induces the apoptosis of 
transgenic OT-II CD4
+ 
SP cells (Anderson et al., 2005). In this experiment, I analyzed the 
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frequency of transgenic OT-II CD4
+ 
SP cells in the thymus of Lmnb1
f/f
; OT-II; RIP-
mOVA; FN1Cre and the littermate control Lmnb1
f/f
; OT-II; RIP-mOVA. As reported in 
previous studies, RIP-mOVA led to a dramatic reduction of CD4
+ 
SP in both Lmnb1 
mutant and control thymus (Fig 3-5D, left). To measure the efficiency of RIP-mOVA-
induced negative deletion, I first calculated the ratio of residual CD4
+ 
SP cells between 
the Lmnb1
f/f
; OTII; RIP-mOVA thymus and the Lmnb1
f/f
; OTII thymus, which indicated 
the percentage of surviving CD4
+ 
SP cells post negative selection. The deletion efficiency 
was then calculated (Equation =100%-percentage of survival) (Metzger et al., 2013). 
Consistent with previous reports, RIP-mOVA induced more than 80% deletion of 
transgenic OT-II CD4
+ 
SP cells in the control thymus, while a slightly reduced deletion 
(~60%) of OT-II CD4
+ 
SP was observed in Lmnb1 mutant thymus (Fig 3-5D, right). I 
would expect more reduced efficiency of negative selection if Lmnb1 were completely 
deleted in mTECs as the residual WT mTECs could ameliorate the defects. This suggests 
that lamin-B1 deficiency in mTECs results in inefficient negative selection. By staining 
with an antibody specific for the transgenic OT-II TCR, I further found a significant 




 T cells in peripheral immune 
organs such as the spleen and lymphoid node (data not shown) in Lmnb1 mutant mice 
(Fig 3-5E). This result indicates that an increased number of transgenic OT-II CD4
+ 
SP 
cells escape negative deletion in Lmnb1 mutant thymus. Taken together, the results from 
transgenic TCR mouse models demonstrate that lamin-B1 is important for cTEC-
mediated positive selection and mTEC-mediated negative selection processes.   
I further investigated how lamin-B1 deficiency impacted the functional capacity 




Fig 3-6. Lamin-B1 deficiency in TECs leads to reduced MHCII expression and 
defective antigen presentation capacity. (A) Flow cytometry analysis of MHCII reveals 
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a loss of MHCII
high





cTEC subsets in control Lmnb1
f/f
 (n=6) and 
Lmnb1 mutant (n=5) thymus. (B) Flow cytometry analysis of MHCII expression reveals a 
reduction of MHCII
high





mTEC subsets in control Lmnb1
f/f
 (n=6) and 




mTEC subsets in control Lmnb1
f/f
 (n=6) and Lmnb1 mutant (n=5) thymus. (D) 
Proliferative response of naïve OT-II CD4
+
 T cells stimulated by purified mTEC and 
cTEC from 2-month-old control Lmnb1
f/f
 and Lmnb1 mutant thymus. The numbers of 
OT-II CD4
+
 T cells were counted 7 days after co-culture in the presence of 10 nM OVA 
323-339 peptide. All data shown are representative of at least 3 independent experiments 
and are shown as mean ± SEM. Student’s t test: *, P < 0.05; **, P < 0.01; ***, P < 0.001; 












by interactions between TCRs expressed on thymocytes and MHC-peptide complexes 
presented on TECs. Expression of MHC class II molecules on TECs plays key roles in 
mediating proper selections for functionally competent and self-tolerant T cells. It has 





subsets based on the expression levels of MHCII molecules and a decline in the most 
differentiated MHCII
high 
TECs is a hallmark change in aged mouse thymus (Chinn et al., 
2012; Gray et al., 2006). Strikingly, I found a nearly complete loss of MHCII
high
 cTEC 
subpopulation in Lmnb1 mutant thymus (Fig 3-6A), which has been suggested as the key 
population mediating the positive selection (Gray et al., 2006). While Lmnb1 depletion in 
mTECs caused a mild reduction in frequency of MHCII
high
 subset (54 ± 4% in WT and 
42 ± 3% in Lmnb1 mutant thymus; P value=0.003) (Fig 3-6B), I found a ~30% 
(MHCII
high 
subset) and a ~50% (MHCII
low 
subset) reduced expression level of MHCII 
molecules on Lmnb1 mutant mTECs (Fig 3-6C), indicating a reduced capability for 
antigen presentation. Previous studies suggested that TEC-mediated selection was 
executed in a manner analogous to antigen presentation and activation of T cells for 
proliferation in the peripheral (Gray et al., 2006). Therefore, I purified cTECs and 
mTECs from WT and Lmnb1 mutant thymus and then assessed their capacity to present 
cognate OVA peptide to stimulate proliferation of naïve transgenic OT-II CD4
+
 T cells in 
vitro (see method). As expected, Lmnb1 mutant mTECs or cTECs exhibited a poor 
capability to stimulate proliferation of OT-II CD4
+
 T cells after 7-day in vitro co-culture 
(Fig 3-6D), further supporting the idea that defective positive and negative selection 
observed in Lmnb1 mutant thymus was at least in part due to low efficacy in antigen 




 In this study I further characterized the functional roles of lamin-B1 in the thymus, 
which showed an age-associated reduction in TECs as discussed in Chapter 2. My data 
demonstrated that lamin-B1 was pivotal for establishing a proper thymic niche 
environment to foster normal  but not  T-cell development. Using Foxn1Cre-
mediated deletion, I showed that TEC-specific deletion of Lmnb1, but not Lmnb2 and 
Lmna, resulted in severe thymic atrophy with significantly reduced cellularity and 
abnormal thymic architecture. Intuitively, this suggested a lamin-B1-specific function in 
TECs as a recent study indicated that lamin-B1 and -B2 might have unique roles in the 
developing brain (Lee et al., 2014). However, since the assembly of each lamin into the 
NL depends primarily on the total lamin protein concentration present in the nucleus 
(Guo et al., 2014), another plausible explanation is that lamin-B1 is the most abundant 
lamin and lamin-B2 and/or -A/C cannot compensate for the defects caused by lamin-B1 
deficiency in TECs. Thus, the striking phenotypes upon Lmnb1 depletion in TECs may 
not simply indicate lamin-B1-specific functions in TECs. Further dissection of the role 
for lamin-B1 and other lamins in different cell types, or using genetic models to test 
rescue capability of individual lamins, should shed light on how different lamins perform 
specific and shared functions during tissue building and homeostasis.   





 TECs in both aged and Lmnb1 mutant thymus. Previous lineage tracing data 




 epithelial cell from an E12 embryonic thymus could 
differentiate into both mTECs and cTECs after transplantation into a WT fetal thymic 




 TECs present in the adult thymus 
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 epithelial progenitors was also reported during irradiation-induced transient 
thymic atrophy and occurred prior to complete thymic recovery, indicating that TEC 
progenitors could be reactivated in the adult thymus for regeneration (Popa et al., 2007). 




 TEC precursors in aged thymus may 
differ from that in the irradiation-induced atrophy model as it is unlikely for TEC 
progenitors to be reactivated in aged thymus without injury or stress. One reasonable 




 TEC precursors is the result of inefficient 
generation of mature cTEC and mTEC from these precursors due to a defective 
differentiation program caused by age-associated extrinsic (e.g., inflammatory thymic 
environment) or intrinsic (e.g., lamin-B1 reduction) changes in aged thymus. Consistent 
with this, a significant reduction in most mature MHCII
high 
TEC subsets is one of major 
changes in TEC compartment associated with aging. Interestingly, FACS analysis 











 TEC precursors. For the future work, keratin IF staining of FACS isolated DN-




 TEC precursors. 
If they are progenitors, further transcriptome analysis should shed light on molecular 
mechanism mediating age-associated thymic involution.  
How does lamin-B1 deficiency in TECs promote thymic adiposity? It is well 
documented that adipogenic differentiation of cells is mainly induced by activation of 
peroxisome proliferator activated receptor gamma (PPARγ), a nuclear receptor regulating 
the transcriptional program required for differentiation of fat cells. Previous studies have 
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shown a link between the nuclear lamina (NL) and PPARγ-mediated adipogenesis. For 
example, over-expression of WT lamin-A or a mutant lamin-A identified in Dunnigan-
type family partial lipodystrophy (FPLD) prevented differentiation of 3T3-L1 
preadipocytes to adipocytes by inhibition of PPARγ2 expression (Boguslavsky et al., 
2006). Furthermore, the NL protein, Emerin, was found to regulate adipogenesis by 
modulating the expression and activity of PPARγ (Tilgner et al., 2009). Finally, dynamic 
reorganization of the NL and cytoskeleton during fat cell differentiation also implies the 
potential role of NL in adipogenesis (Verstraeten et al., 2011). While the role of lamin-B1 
in adipogenesis has not been reported, it may influence adipogenesis by regulating proper 
NL assembly and organization, or regulation of PPARγ in TECs. Of interest, I found a 
significant down-regulation of Ghrelin receptor (GHSR) in Lmnb1 mutant mTECs, 
indicating enhanced PPARγ activity in mutant mTECs since GHSR-mediated signaling 
pathway has been demonstrated to play a key role in inhibiting activation of PPARγ 
signaling in TECs and preventing age-related thymic adiposity (Youm et al., 2009). 
While I did not detect a significant change of PPARγ at mRNA level in Lmnb1 mutant 
mTECs (data not shown), further experiments will be performed to assess nuclear PPARγ 
activity in Lmnb1 mutant TECs.  
Interestingly, TEC-specific Lmnb1 mutant thymus exhibited remarkably similar 
phenotypes to that of the aged thymus, covering almost all reported age-related 
alterations, such as skewing of the cTEC:mTEC ratio, a decline in the most differentiated 
MHCII
high 
subsets, disorganization of TEC compartment and enhanced adiposity. The 
decline of several other proteins such as Foxn1 have been reported to contribute to 
thymic aging as mutant thymuses also show some of age-related phenotypes. However, to 
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my knowledge, the Lmnb1 mutant thymus is the first model displaying all known age-
related defects. In summary, these findings suggest that lamin-B1 may function as a 
novel gene regulatory node controlling thymic homeostasis. Therefore, identification of 
lamin-B1-regulated transcriptional program in TECs and comparative analysis with age-
associated transcriptome changes should shed light on the molecular mechanism 
governing thymic homeostasis and aging. In the next Chapter, I will further discuss my 
effort to apply RNA-seq to analyze the TEC transcriptome in both aged and Lmnb1 
mutant thymus. 
 






mice were generated by EUCOMM projects and Lmna
f/f
 allele was 
generated by Dr. Youngjo Kim (Kim and Zheng, 2013). All mice were further 









RIP-mOVA mice were purchased from Jackson 
Laboratory.  
 
Tamoxifen (TAM) induced Lmnb1 deletion 
Stock solution of TAM (20 mg/ml, Sigma) was prepared by dissolving TAM powder in 
one volume of 100% ethanol at 55 °C for 2 min and then mixed well with 9 volumes of 
pre-warmed (55 °C) corn oil. To induce Lmnb1 (exon 2) deletion, 2-month-old mice were 
treated with a single intraperitoneal (IP) injection of TAM (1mg/10 g body weight/day) 
for five successive days and with TAM kept in the drinking water (0.025 mg/ml). 
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Thymus phenotypes were analyzed 4 weeks after the 5th TAM injection. 
 
Histology and Immunofluorescence Microscopy 
Freshly isolated thymuses were embedded in OCT (Leica microsystems) and frozen 
immediately in −80°C. For H&E and Oil Red staining, 10 μm sections were fixed in 4% 
formaldehyde solution for 10 min and then processed according to standard protocols. 
For keratin staining, 10 μm sections were fixed in a 1:1 mixture of acetone and methanol 
at −20°C for 10 min and then washed with PBS for 3 times. After blocking, samples were 
stained with primary antibodies containing rat-anti-keratin8 (Troma-1, DSHB, 1:20) and 
rabbit-anti-keratin5 (Biolegend, 1:300) at room temperature (RT) for 1 hour, followed by  
Alexa488 goat anti-rat and Alexa568 goat anti-rabbit (Invitrogen) secondary antibodies 
Samples were then mounted with ProLong® Gold Antifade Mountant (Fisher Scientific) 
and allowed to dry overnight at RT before imaging. Neutral lipid staining was performed 
after keratin staining following the manufacturer’s protocol (Life technology). Confocal 
images were acquired using a laser-scanning confocal microscope (Leica SP5) with a 
20X or 63X objectives. Images were processed using ImageJ.  
  
Quantitative real-time PCR 
Detailed protocol was described in the 2nd chapter. Primer sequences were listed as 
follows. GHSR: forward primer, GGAAAACAGATATCTTCCCACG; and reverse 
primer, GGGACCAGAACCACAAACAG. PPARγ2: forward primer,  
GCCTATGAGCACTTCACAAGAA; reverse primer, TGCGAGTGGTCTTCCATCAC. 
 
Flow cytometry analysis 
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Detailed protocol was described in the 2
nd
  Chapter. The following FACS monoclonal 
antibodies were used for this section: CD45, EpCAM, Ly51, I-A/I-E (MHCII), CD4, 
CD8, TCRβ, TCR, CD69, TCRβV5.1 (Biolegend) and UEA-1 (Vector laboratory). 
Data was analyzed with FlowJo software (Tree Star). 
 
In vitro OTII CD4 T cell proliferation assay 
Purified TEC subsets (~10,000) were co-cultured with 40,000 splenic OT-II CD4
+
 T cells 
in the presence of 10 nM OVA 323-339 (GeneScript) in U-bottom 96-well plate (Gray et 
al., 2006). OT-II CD4
+
 T cells were isolated using MojoSort Mouse CD4
+
 T Cell Kit 
(Biolegend). Splenic dendritic cells were purified by FACS sorting and were included as 
a positive control. After culture for 7 days, cells were stained with PE-CD4 and counted 
by FACSAria
TM
 III with 100,000 spike-in FITC-labeled BD Calibrite beads (BD 
bioscience). The absolute number of OT-II CD4
+
 T cells was calculated based on the 
ratio of PE-CD4 vs FITC-beads. 
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Chapter 4: Transcriptome profiling identifies lamin-B1-mediated and aged-
associated signatures in TECs 
 
Summary 
Whole genome analysis of age-associated transcriptome changes in TECs is 
critical for the understanding of the molecular drivers of thymic involution. So far, only 
one study applied DNA microarray for transcriptional profiling of thymic stromal subsets 
during early stage of thymic involution (ranging from 1 to 6 month of age). However, 
similar transcriptome analysis for late stage of thymic involution is lacking and as a result, 
the mechanisms mediating postnatal thymic homeostasis remain largely unknown. Using 
RNA-seq technology, I report here, for the first time, whole genome-wide transcriptome 
profile of two major TEC subsets, cTEC and mTEC, from young (2-month), early-stage 
involution (6-month) and late-stage thymic involution (20-month). My RNA-seq data 
reveal a significant enrichment of genes in the inflammatory/immune response in mTECs 
during early involution stage, indicating that acquisition of an inflammatory signature is a 
hallmark of early involution. I also show that an enrichment of genes in non-TEC lineage 
development and functions is a common feature for both cTECs and mTECs from aged 
mouse thymus. Furthermore, I observed that the transcriptional alterations seen in cTECs 
and mTECs isolated from the 6-month-old Lmnb1 mutant thymus were remarkably 
similar to those observed in the 20-month-old WT thymus, indicating that Lmnb1 
deficiency accelerates age-associated transcriptional program in TECs. Deep mining 
RNA-seq data should provide a conceptual framework for understanding the mechanism 





                 
The recent advance in high-throughput sequencing technology has made whole 
genome transcriptional profiling a widely available tool to accelerate scientific progress. 
In line with this, transcriptome analyses of several key cell populations in the immune 
system by the Immunological Genome Project Consortium have generated important 
insights into the principles of immune system development, maintenance and function 
(Benoist et al., 2012). Much effort has recently been made in the TEC field to dissect 
transcriptional features of distinct TEC subsets using genome-wide approaches. Despite 
the limited number of studies, they have expanded our understanding of TEC biology 
(Brennecke et al., 2015; Sansom et al., 2014; St-Pierre et al., 2013). For example, 
transcriptional profiling of cTEC and mTEC isolated from neonatal thymus highlights 
substantial divergences in transcriptional landscape of these two TEC subsets (St-Pierre 
et al., 2013). Using single-cell RNA-seq of individual MHCII
high
 mTEC, the Hollander 
group shows that mTECs are capable of expressing up to 19,293 protein-coding genes, 
which is the highest number of expressed genes in any known cell type. This high 
number of expressed genes in mTECs ensures a comprehensive coverage of self-antigens 
in mTECs and efficiently eliminates self-reactive T cells to establish central tolerance. 
Despite much progress in the understanding of TEC developmental programs, the 
molecular pathways that regulate age-associated involution still remain largely unknown. 
Until very recently, a global transcriptional profiling of thymic stromal subsets uncovered 
unexpected age-related transcriptional changes during early thymic involution (Ki et al., 
2014). While the reduction of Foxn1 expression is generally accepted as a prime mediator 
of thymic involution (Chinn et al., 2012), Foxn1 was not identified as an differentially 
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expressed gene in mTECs during early thymic involution (6-month), arguing against the 
central role of Foxn1 in involution. The study concluded that the predominant 
transcriptional features in TECs during early thymic involution include reduced 
expression of cell-cycle-related genes in MHCII
low
 mTECs and E2F3 targets in cTEC and 
MHCII
low
 mTECs. In addition, increased expression of proinflammatory cytokines in 
thymic DC is another hallmark of early involution, indicating that inflammation plays a 
more important role than previously thought in triggering thymic involution. Due to 
dramatically reduced TEC cell numbers during late stage of thymic involution, 
transcriptome analysis of age-associated changes in TECs during late stage has not been 
reported. Here, I present transcriptome profiling of two major TEC subsets, cTEC and 
mTEC, from young (2-month), early involution (6-month) and late involution (20-month) 
thymuses. My RNA-seq datasets provide a valuable resource for the TEC and 
immunology fields to further dissect the molecular mechanism underlying age-associated 
thymic involution. Importantly, I show that the TEC transcriptional landscape in 6-
month-old Lmnb1 mutant thymus exhibits remarkable similarity to that in the 20-month-
old aged WT thymus. Together with the TEC phenotypes observed upon Lmnb1 
depletion described in Chapter 3, these results strongly suggest that age-associated loss of 
lamin-B1 in TECs accelerates age-related transcriptome changes and triggers a 








Identification of age-associated transcriptional signatures in cTECs  
To explore the molecular mechanism underlying age-related thymic involution, I 
decided to apply RNA-seq to profile the transcriptome of TECs isolated from different 
stages of WT thymuses. I chose RNA-seq rather than microarray analysis because RNA-
seq offers higher sensitivity, resolution and less technical variation. To identify age-
related differential expression of genes (DEGs), I applied stringent criteria for 
comparison and considered DEGs as those genes with fold change ≥ 2 relative to a 2-
month-old WT control with adjusted false discovery rate (FDR) <0.05 and p value <0.05 
(See the method section).  I will first report age-associated transcriptional changes related 
to cTEC and then turn to mTEC later in this chapter.         
While no significant age-related DEGs were reported in cTECs in early involution 
(Ki et al., 2014), the study used microarray for gene analysis. The lower detection 
sensitivity of microarray technology may mask some real DEGs. Thus, I employed RNA-
seq to reassess gene expression associated with early involution in cTECs from mice at 2 
and 6 months of age. I identified 74 up- and 90 down-regulated genes (Fig 4-1A) and 
then performed Gene Ontology (GO) term analysis to examine biological functions 
altered in cTECs during early involution. Consistent with the early report, no functional 
category related to thymic development and homeostasis was identified.  
Since transcriptional profiling of TECs from late thymic involution has not been 
reported, I then decided to evaluate gene expression changes in cTECs from mice at 2 
and 20 months of age. Using the same criteria, I identified 1486 up- and 446-down-




Fig 4-1. RNA-seq analysis reveals age-related transcriptional signatures in cTECs.  
(A) Summary of the number of up- (white) and down-regulated (black) genes (fold 
change ≥2) in WT cTECs during early involution (6-month) and late involution (20-
month). (B) The top10 significant GO terms for the up-regulated genes are involved in 
development and function for the non-cTEC cells in cTECs from 20-month-old WT 
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thymus. (C)-(D) The top significant GO terms for up- (C) or down-regulated (D) genes 
with regards to age-associated phenotypes in cTECs from 20-month-old WT thymus. (E) 
The genome browser views show up-regulation of IL-6 expression in aged cTEC (left) 
and qRT-PCR analysis of IL-6 expression in young (2-month) and aged (20-month) 
cTECs (right). (F) qRT-PCR analysis reveals reduced expression of Dll4 in aged cTECs. 
All data shown are representative of at least 3 independent experiments and are plotted as 


















GO term analysis revealed a significant enrichment of genes required for the 
development of many tissues and organs other than the thymus (Fig 4-1B, top10 listed). 
This pattern of enrichment was similar to that observed in cTECs from 6-month-old 
Lmnb1 mutant thymus (Fig 4-4B, discussed in the later section). A recent study reported 
that cTECs from young mouse thymus express up to 84% of protein-coding genes 
covering nearly all peripheral tissues, which contributes to shape the maximal repertoire 
of self-peptides for positive selection (Sansom et al., 2014). The exact physiological 
meaning of up-regulation of non-cTEC lineage genes in aged cTECs is not clear, but this 





SP cells observed in aged thymus. 
Additional GO term analyses further revealed up- and down-regulation of 
important processes involved in age-associated thymic phenotypes, respectively (Fig 4-
1C and D). I first found an enrichment of genes associated with cell adhesion, migration 
and extracellular matrix organization (Fig 4-1C), which correlated with disruption of 
TEC organization and architecture in aged thymus (Fig 3-2B, Chapter 3). Consistent with 
enhanced adipogenesis in aged thymus, I observed a large fraction of up-regulated genes 
enriched in response to lipid, mesenchyme development and fat cell differentiation, 
providing a molecular mechanism for the possible generation of adipose cells from TECs 
(Fig 4-1C). Early studies demonstrated that p38 and/or ERK1/2 MAPKs played critical 
roles in regulating production of inflammatory cytokines such as IL-6 in cultured human 
thymic epithelial cells in vitro (Colombara et al., 2005; Mainiero et al., 2003). Whether or 
not the same mechanisms involved in promoting elevated inflammatory cytokines in 
TECs from aged mouse thymus in vivo is not known. GO term analyses further revealed 
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that up-regulated genes are highly enriched in the MAPK and ERK1/2 cascades (Fig 4-
1C) and I also confirmed more than 100-fold increased production of IL-6 in cTEC from 
20-month-old WT thymus (Fig 4-1E), indicating conserved mechanisms mediating 
inflammatory cytokine production in the mouse thymus.  Further, I observed many genes 
involved in response to wounding and inflammation, which are in agreement with 
previously reported changes in the inflammation-induced thymic involution model 
(Billard et al., 2011) (Fig 2-5, Chapter 2). Consistent with impaired thymopoiesis upon 
aging, GO term analysis of down-regulated genes revealed an enrichment of genes with 
functions in T-cell activation, aggregation and differentiation (Fig 4-1D). Two key genes, 
Dll4 (Delta Like Canonical Notch Ligand 4) and Foxn1, were identified from all 3 
categories. Dll4 is required for a functional thymic niche to promote survival and 
differentiation of early thymocyte progenitors (Koch et al., 2008). I observed a ~60% 
reduction in Dll4 expression in cTECs during the late stage of thymic involution (Fig 4-
1F), suggesting that a decline of Notch signaling contributes to impaired thymopoiesis. 
The expression of Foxn1 also showed a similar reduction (~60%, data not shown) as Dll4 
in cTECs, but not in mTECs, which was consistent with a recent study showing 
expansion of Foxn1-negative cTECs during the late thymic involution stage (O'Neill et 
al., 2016). Since a recent genome-wide Foxn1 Chip-seq study demonstrates that Foxn1 
regulates key genes involved in antigen processing and selection for T-cell development 
(Zuklys et al., 2016), decreased Foxn1 expression in cTECs may further exacerbate the 






Age-associated transcriptional features in mTECs             
A previous study concluded that down-regulation of cell-cycle related genes in 
mTEC subset is a key feature of early thymic involution (Ki et al., 2014). However, the 
study chose a one-month-old thymus as young control group, which is at a time when the 
thymus undergoes quick development, expansion and growth. Additionally, there were 
no significant changes of cell-cycle genes in mTECs between 3-month-old and 6-month-
old thymus shown in the same study. Thus, the conclusions from this initial study may 
overestimate the contribution of cell-cycle genes to early thymic involution. To identify 
early thymic involution related transcriptional signatures, I compared the expression 
profiles of mTECs from mice at 2- and 6-month of age and initially identified 92 up- and 
63 down-regulated genes (Fig 4-2A). GO term analysis of up-regulated transcripts 
revealed a significant enrichment of genes with functions in inflammatory/immune 
response, wound healing and response to IL-1 (Fig 4-2B), indicating an inflammatory 
signature in mTECs. Together with my early results showing increased expression of 
proinflammatory cytokines in sirp
+
 DC and macrophage upon aging (Chapter 2), these 
data strongly suggest that thymic myeloid lineage cell-derived inflammation plays a key 
role in triggering onset of early thymic involution. 
I next evaluated the gene expression profile in mTECs from mice at 2- and 20-
month of age and identified 545 up- and 754 down-regulated genes associated with late 
thymic involution (Fig 4-2A). GO term analysis revealed a significant enrichment of up-
regulated genes with functions in non-mTEC lineage development and functions (Fig 4-
2C, top10 listed), a similar pattern also observed in cTECs from aged thymus (Fig 4-1B). 




Fig 4-2. RNA-seq analysis identifies age-related transcriptional features in mTECs. 
(A) Summary of the number of up- (white) and down-regulated (black) genes (fold 
change ≥2) in WT mTECs during early involution (6-month) and late involution (20-
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month). (B) The top significant GO terms for up-regulated genes in mTECs during early 
thymic involution (6-month). (C) The top10 significant GO terms for the up-regulated 
genes are involved in non-mTEC lineage development and function in mTECs from 20-
month-old thymus. (D) qRT-PCR analysis of parathyroid gland related genes GCM2, 
Hoxa3 and Tbx1 in young (2-month) and aged (20-month) WT mTECs. (E) The top 
significant GO terms for the up-regulated genes with regarding to age-associated 
phenotypes in mTECs from 20-month-old thymus; (F) qRT-PCR analysis of selected up-
regulated genes in young (2-month) and aged (20-month) mTECs: IL6 (top left); TGFβ 
receptor II (top right); Notch signaling (bottom). (G) The top significant GO terms for 
down-regulated genes with respect to age-associated phenotypes in mTECs from 20-
month-old thymus. All data shown are representative of at least 3 independent 
experiments and are plotted as mean ± SEM. Student’s t test: *, P < 0.05; **, P < 0.01; 












a transcriptional factor for parathyroid gland, in mTECs (not found in cTECs) from 20-
month-old aged thymus. In addition, I also found increased expression of parathyroid 
gland related genes including Hoxa3 and Tbx1 in mTECs from aged thymus (Fig 4-2D). 
Given that the thymus and parathyroid gland are derived from the same primordium 
during early embryonic stage, these results strongly suggested that the altered 
transcriptional program in aged mTECs led to non-mTEC lineage differentiation and in 
turn interrupted appropriate functions of mTECs.  
Further analysis revealed similar enrichments in functional categories observed in 
cTECs, including thymic structural organization, response to lipid/mesenchyme 
development (adiposity-related), MAPK and ERK1/2 cascades and intrathymic 
inflammatory reaction (Fig 4-2E). I also confirmed a more than 10-fold increased 
production of IL-6 in aged mTECs using qRT-PCR assay (Fig 4-2F, top left). These 
results suggested that age-associated changes of intrathymic environment might lead to 
common transcriptional alterations in both cTECs and mTECs.  
A recent study demonstrated that TGFβ signaling played a negative regulatory 
role in the establishment and function of the thymic medulla by inhibiting differentiation 
and proliferation of mTECs (Hauri-Hohl et al., 2014). However, the role of TGFβ 
signaling in thymic aging has not been investigated. Interestingly, I observed a large 
number of up-regulated genes involved in the TGFβ signaling pathway and further 
confirmed the increased expression of TGFβ receptor II in mTECs from 20-month-old 
WT thymus (Fig 4-2E, marked with one red star; Fig 4-2F, top right). These data 
indicated that reduced proliferation and differentiation of mTECs documented in aged 
thymus was caused at least in part by enhanced TGFβ signaling. Interestingly, I found 
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many up-regulated genes enriched in the Notch signaling pathway (Fig 4-2E, marked 
with two red stars) and subsequent qRT-PCR analysis validated the increased expression 
of key Notch signaling components, such as Notch3, Hey1 and Hey2 (Fig 4-2F, bottom). 
While Notch signaling pathway is well studied in the T cell context, the role of Notch 
signaling in TEC development is largely unknown. A recent study reported that Notch 
signaling was active in cTECs and/or early immature mTEC subset and that repression of 
Notch signaling in early immature mTEC subset was required for efficient differentiation 
and maturation of mTECs (Goldfarb et al., 2016). Thus, enhanced Notch signaling in 
mTECs upon aging may interrupt the normal differentiation program and partially 
prevent immature mTEC from progressing to a mature stage. Consistent with this, GO 
term analysis of down-regulated genes also revealed an enrichment of genes with 
functions in epithelial cell differentiation and development (Fig 4-2G). I also found a 




 TEC progenitors based on keratin IF assay and a 






) in both natural 
aged and Lmnb1 mutant thymuses (Chapter 3, Fig 3-2 B-D). Additionally, an enrichment 
of lipid metabolic and catabolic process was also observed in down-regulated genes and 
might contribute to age-related ectopic adiposity in the thymus (Fig 4-2G). 
 
Depletion of Lmnb1 in TECs accelerates age-associated transcriptional program 
Since a TEC-specific ablation of Lmnb1 caused phenotypes similar to those 
observed in the aged WT thymus, I next explored the transcriptional changes in TECs 
from 2- and 6-month-old Lmnb1 mutant thymus and examined whether these 




Fig 4-3. Transcriptional signatures of Lmnb1 mutant TECs from 2-month-old 
thymus revealed by RNA-seq. (A) Graphs show the overlap of up- (top) or down-
regulated (bottom) genes (fold change ≥2) between aged (20-month) WT and Lmnb1 
 
 116 
mutant (2-month) cTECs. (B) The top significant GO terms for up- (top) or down-
regulated (bottom) genes with regards to lamin-B1-mediated phenotypes in cTECs from 
2-month-old mutant thymus. (C) Graphs summarize the overlap of up- (top) or down-
regulated (bottom) genes between aged (20-month) WT and Lmnb1 mutant (2-month) 
mTECs. (D) The top significant GO terms for down-regulated genes related to lamin-B1-



















report transcriptional profile for the 2-month-old Lmnb1 mutant cTEC and mTEC and 
then turn to 6-month-old Lmnb1 mutant cTEC and mTEC. Using a 2-fold cut off, I found 
that the transcriptional profiles of TECs from 2-month-old Lmnb1 mutant thymus were 
not remarkably similar (~12% to 29%, shared numbers of DEGs compared to 2-month-
old WT thymus) to that observed in 20-month-old aged TECs (Fig 4-3A and C). In 
cTECs, the Lmnb1 mutant only shared 176 up- and 140 down-regulated genes with aged 
group, respectively. Despite relatively few genes in each category, GO term analysis of 
altered genes in 2-month-old Lmnb1 mutant cTECs still revealed some similar functional 
categories as shown in aged cTECs. They also included thymic structural organization, 
response to lipid/mesenchyme development (adiposity-related), MAPK and ERK1/2 
cascades and intrathymic inflammatory response in up-regulated genes and down-
regulation of T-cell activation/differentiation (Fig 4-3B, 2-month-old Lmnb1 mutant 
cTECs; Fig 4-1C and D, 20-month-old cTECs). For up-regulated DEGs in Lmnb1 mutant 
mTECs, I observed an enrichment of similar functional categories as those shown in the 
aged group (Fig 4-3D, 2-month-old Lmnb1 mutant mTECs; Fig 4-2E, 20-month-old 
mTECs). Unlike the 20-month aged group, Notch signaling was not identified in GO 
term analysis in 2-month-old Lmnb1 mutant mTECs because it did not meet 2-fold 
increase criterion. However, several components in Notch signaling pathway including 
Notch3/4, Hey1 and Hey2 did show increased expression (ranging from 1.3 to 1.5 fold) 
in Lmnb1 mutant mTECs (data not shown), indicating enhanced Notch signaling as a 
result of Lmnb1 depletion in mTECs in 2-month-old mutant thymus.  
Next I decided to perform transcriptional profiling of cTECs and mTECs isolated 
from 6-month-old Lmnb1 mutant thymus. Strikingly, Lmnb1 mutant cTECs and mTECs 
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from 6-month-old thymus exhibited a highly similar transcriptional profile to those in 20-
month-old WT thymus. I will first describe data analysis for cTECs and then discuss 
mTECs. Using the same criteria (2-fold cut off), I initially found that 6-month Lmnb1 
mutant cTECs shared 968 up- and 191 down-regulated genes with 20-month-old aged 
group (total 1486 up- and 446 down-regulated DEGs), respectively. These results were 
striking as DEGs in 6-month-old Lmnb1 mutant thymus shared ~65% of up-regulated 
genes and ~45% down-regulated genes observed in the 20-month-old age group while 6-
month-old WT controls exhibited less than 10% commonly altered genes with 20-month-
old age group (data not shown). GO term analysis of up-regulated genes further revealed 
a highly significant enrichment of non-cTEC lineage development and functions (Fig 4-
4B, top10 listed), reflecting a trend that was similar to that identified in cTECs from 20-
month-old WT thymus (Fig 4-4B and Fig 4-1B). For up-regulated genes, GO term 
analysis also identified very similar functional categories as observed in aged cTECs 
including thymic structural organization, response to lipid/mesenchyme development/fat 
cell differentiation (adiposity-related), MAPK and ERK1/2 cascades and intrathymic 
inflammatory reaction (Fig 4-4C and Fig 4-1C). Of interest, a large number of up-
regulated genes exhibited similar level of change. For example, cTECs from 20-month-
old aged thymus exhibited ~127 fold increased expression of IL6 (Fig 4-1E) and Lmnb1 
mutant cTECs from 6-month-old thymus expressed ~112 fold increase of IL-6 transcripts 
(Fig 4-4E). For down-regulated genes, similar enrichments were observed such as T-cell 
activation, aggregation and differentiation. While Dll4 was not identified as a DEG in 6-
month Lmnb1 mutant cTECs, the expression of Foxn1 in Lmnb1 mutant cTECs showed a 




Fig 4-4. Accelerated age-associated transcriptional program in Lmnb1 mutant 
cTECs from 6-month-old mutant thymus revealed by RNA-seq. (A) Graphs show the 
overlap of up- (top) or down-regulated (bottom) genes (fold change ≥2) between aged 
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(20-month) WT and Lmnb1 mutant (6-month) cTECs. (B) The top10 significant GO 
terms for up-regulated genes in non-cTEC lineage development and function in Lmnb1 
mutant cTECs from 6-month-old thymus. (C)-(D) The top significant GO terms for up- 
(C) or down-regulated (D) genes with regards to lamin-B1-mediated phenotypes in 
cTECs from 6-month-old mutant thymus. (E) The genome browser views show up-
regulation of IL-6 expression in Lmnb1 mutant (6-month) cTECs (left); qRT-PCR 
analysis of IL-6 expression in Lmnb1 mutant cTECs from 2- and 6-month-old thymuses 
(right). All data shown are representative of at least 3 independent experiments and are 
















shown), which might lead to similar global transcriptional changes that result in defective 
thymopoiesis.  
For mTEC, I first found that mTECs from 6-month-old Lmnb1 mutant thymus 
shared 411 up-regulated genes with aged WT controls (411 out of total 545), covering as 
high as ~75% of the up-regulated genes seen in the aged WT group (Fig 4-5A, top). Less 
dramatically, the 6-month Lmnb1 mutant mTEC shared ~55% of down-regulated genes 
with 20-month-old aged group (Fig 4-5A, bottom; 417 out of total 754). GO term 
analysis again revealed a significant and similar enrichment of up-regulated genes with 
functions in non-mTEC lineage development and functions (Fig 4-5B, top10 listed; Fig 
4-2C for 20-month-old aged controls). I also observed a very similar increased expression 
of parathyroid gland-related genes, such as GCM2, Hoxa3 and Tbx1, in Lmnb1 mutant 
mTECs from 6-month-old thymus (Fig 4-5C; Fig 4-2D for 20-month-old aged controls). 
Further analysis revealed more similar enrichments in functional categories observed in 
aged mTECs including thymic structural organization, response to lipid/mesenchyme 
development (adiposity-related), MAPK and ERK1/2 cascades, cellular response to 
TGFβ and intrathymic inflammatory reaction (Fig 4-5D). Using qRT-PCR assay, I 
validated the increased expression of IL-6, TGFβ receptor II and Notch signaling 
components including Notch3, Hey1 and Hey2 in 6-month Lmnb1 mutant mTEC (Fig 4-
5E), and showed that the altered levels were similar to those seen in 20-month aged WT 
mTECs (Fig 4-2F). GO term analysis of down-regulated genes identified a similar 
enrichment of genes as that in aged group with functions in epithelial cell differentiation 
and lipid catabolic/transport process (Fig 4-5F), consistent with the ectopic adiposity 




Fig 4-5. RNA-seq analysis reveals accelerated age-related transcriptional program 
in Lmnb1 mutant mTECs from 6-month-old mutant thymus. (A) Graphs show the 
overlap of up- (top) or down-regulated (bottom) genes (fold change ≥2) between aged 
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(20-month) WT and Lmnb1 mutant (6-month) mTECs. (B) The top10 significant GO 
terms for up-regulated genes in non-mTEC lineage development and function in 6-month 
Lmnb1 mutant mTECs. (C) qRT-PCR analysis of parathyroid gland-related genes GCM2, 
Hoxa3 and Tbx1 in 2- and 6-month Lmnb1 mutant mTECs. (D) The top significant GO 
terms for up-regulated genes with regards to lamin-B1-mediated phenotypes in mTECs 
from 6-month-old mutant thymus. (E) qRT-PCR analysis of select up-regulated genes in 
2- and 6-month Lmnb1 mutant mTECs: IL6 (top left); TGFβ receptor II (top right); Notch 
signaling (bottom). (F) The top significant GO terms for down-regulated genes with 
regards to lamin-B1-mediated phenotypes in mTECs from 6-month-old mutant thymus. 
All data shown are representative of at least 3 independent experiments and are plotted as 














data strongly suggest that Lmnb1-loss-mediated transcriptome change contributes, at least 
in part, to the age-associated change in the transcriptional program in TECs and that this 
in turn leads to the observed degenerative phenotypes. 
 
Discussion 
In this study, I present global gene expression data for two main TEC subsets, 
cTEC and mTEC, covering young stage (2-month), early involution (6-month) and late 
involution (20-month). To my knowledge, this is the first whole genome-wide 
transcriptome profiling of TECs at the late stage of thymic involution. Nonetheless, I 
have to emphasize one caveat before discussing my findings. While I chose standard 
surface markers to isolate cTECs and mTECs, they are still heterogeneous and can be 





 subpopulations based on MHCII expression. As the frequency of TEC subsets 
is not maintained during aging, it is critical to compare transcriptional profiles of 
individual TEC subsets. However, due to the low cell number of TECs collected from 
pooled aged thymuses, it is technically challenging to separate individual cTEC and 
mTEC subpopulations for RNA-seq analyses in this study. With the help of new low-cell 
number RNA-seq and the single-cell RNA-seq technologies, future experiments will use 
more defined TEC subsets for whole genome-wide transcriptional profiling. Nevertheless, 
my RNA-seq data provide novel insight into the age-associated transcriptional landscape 
changes in TECs and will be a valuable resource for the whole TEC research community.         
While decreased Foxn1 expression is commonly accepted as a major factor 
contributing to thymic involution (Chinn et al., 2012), Foxn1 was not identified as a DEG 
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in mTECs in my RNA-seq and in a recently published microarray study (Ki et al., 2014) 
during early thymic involution (6-month). It is possible that Foxn1 is reduced at the 
protein level, without a significant change at mRNA level, in mTECs during early 
involution. However, using a novel Foxn1
G
 reporter allele, a newly published study 
found that there was no significant change of Foxn1 protein level in mTECs between 3-
month-old and 24-month-old thymus (O'Neill et al., 2016). This new evidence strongly 
argues against the central role of Foxn1 in driving early thymic involution. Consistent 
with the previous microarray data, my GO term analysis revealed a significant 
enrichment of up-regulated genes in inflammatory/immune response, wound healing and 
response to IL-1 in mTECs during early involution (Fig 4-2B), indicating that acquisition 
of an inflammatory signature in mTECs is a hallmark of early stage of thymic involution. 
Considering that other groups and my study above (Chapter 2) reported increased 
expression of proinflammatory cytokines in sirp
+
 DC and macrophage in thymus upon 
aging (Ki et al., 2014; Youm et al., 2012), these data strongly suggest that thymic 
myeloid cell-derived inflammation plays a key role in initiating thymic degeneration.  
Surprisingly, GO term analysis also revealed a significant enrichment of up-
regulated genes with functions in non-TEC lineage development and functions in both 
aged cTECs and mTECs. A recent TEC transcriptome profiling showed that both cTECs 
and mTECs expressed peripheral tissue-restricted antigens (TRA), commonly referred to 
as promiscuous gene expression (PGE) (Sansom et al., 2014). The study estimated that 
TECs from young mouse thymus were able to express up to 19,293 protein-coding genes. 
The optimal expression level of these TRAs shapes the maximal repertoire of TCR 
available for the positive and negative selection of developing thymocytes. Dysregulation 
 
 126 
of the PGE program due to age-associated defects in TECs may result in up-regulation of 
some non-TEC lineage genes at the cost of others and may disrupt normal thymopoiesis. 
For example, one interesting case is the ectopic expression of parathyroid specific 
transcription factor GCM2 in aged mTECs (Fig 4-2D), implying that the aged thymus 
may exhibit some features of parathyroid gland. As the main function of the parathyroid 
is to regulate calcium homeostasis with no reported role for supporting thymopoiesis, it is 
reasonable to speculate that ectopic expression of GCM2 in aged mTECs would interfere 
with normal negative selection of auto-reactive T cells and contribute at least in part to 
increased autoimmunity risk during aging (Prelog, 2006).   




 T cells produced by the 
aged mouse thymus had impaired functions (Maue et al., 2009). These T-cell defects 
were mainly attributed to the impact of an aged thymic microenvironment, but not from 
aged T-cell progenitors because functional T cells were generated when HSCs from aged 
mouse were transplanted into young mouse thymus. GO term analyses revealed for the 
first time a deterioration of the intrathymic microenvironment at the transcriptional level, 
affecting thymic structural organization and ectopic adiposity, all of which contributed to 
defective thymopoiesis in aged mouse thymus. One key feature uncovered by RNA-seq 
analysis is an enhanced inflammatory environment within the aged mouse thymus. I 
found more than 100-fold increased production of IL-6 in aged cTECs and 10-fold 
increased expression of IL-6 in aged mTECs, respectively. In Chapter 2, I showed that 
pro-inflammatory cytokines such as IL-6 were able to induce lamin-B1 reduction in 
cultured TECs in vitro. Therefore, increased production of IL-6 from TECs and myeloid 
lineage-derived macrophage and DC in aged mouse thymus may further accelerate lamin-
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B1 loss in TECs. Interestingly, Lmnb1 mutant TECs exhibited remarked similar 
phenotypes and transcriptional changes as aged TECs (Fig 4-4 and 4-5), including 
increased production of IL-6 (Fig 4-4E and 4-5E). This raises the possibility that IL-6 
may play a central role in exacerbating degeneration of aged thymus via positive 
feedback loop, which may help to prevent or reduce the chance of producing too many 
defective naïve T cells within inflammatory microenvironment and may be a beneficial 
aspect of thymic involution. 
One interesting observation from this study is the enhanced Notch signaling in 
both aged and Lmnb1 mutant mTECs. According to the prevailing view, both cTECs and 
mTECs originate from bipotent progenitors. The current model for TEC differentiation 
suggests that bipotent progenitors can either progress “by default” to mature cTECs or 
acquire an mTEC fate in response to other signals, during which repression of Notch 
signaling in early immature mTECs is required for efficient mTEC differentiation and 
progression towards a mature MHCII
high
 stage. In line with this, overexpression of 
Notch1 in TECs resulted in thymic hypoplasia with impaired mTEC maturation 
(Goldfarb et al., 2016). Enhanced Notch signaling in mTECs from aged mouse thymus 
may partially prevent immature mTECs from progressing to a mature stage, which in turn 
interrupts appropriate negative selection and final maturation of native T cells. In 




 TEC progenitors and a 






) in both natural 
aged and Lmnb1 mutant thymus (Chapter 3, Fig 3-2).  
             Interestingly, I found that both cTECs and mTECs isolated from 6-month-old 
Lmnb1 mutant thymus exhibited remarkably similar transcriptional changes as these 
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shown in the 20-month-old WT thymus. How could lamin-B1 loss affect global 
transcriptome in TECs? Lamins, especially lamin-B1, have long been suggested to have a 
role in maintaining heterochromatin and gene regulation (Dechat et al., 2010). Using the 
fly immune organ fat body as a model, our lab reported that depletion of lamin-B led to a 
loss of heterochromatin and depression of a large number of immune responsive, 
inflammatory genes and retrotransposons (Chen et al., 2014; Chen et al., 2016). GO term 
analysis also revealed that age-associated lamin-B loss in the fly fat body mainly affected 
genes related to immune, metabolism, cell fates and cell-cell adhesion. I observed a very 
similar enrichment of functional categories in up-regulated genes in Lmnb1 mutant 
cTECs and mTECs, such as inflammatory response, strongly suggesting that lamin-B1 
might play an evolutionarily conserved role in maintaining tissue homeostasis and 
functions. Given that an age-associated lamin-B1 reduction occurs in TECs upon aging, it 
is plausible that loss of lamin-B1 leads to global transcriptome and epigenome changes in 
TECs and triggers a degenerative cascade in the thymus. In the next chapter I will 
describe my effort to develop a novel low-cell number ChIP-seq technology, which will 
be applied to further dissect how lamin-B1 regulates TEC epigenetic landscape and gene 
expression in my future study. 
           
Materials and methods 
Quantitative real-time PCR 
Primer sequences were listed as follows.  
Dll4: F: AGGTGCCACTTCGGTTACAC; R: GGAGAGCAAATGGCTGATA. 
GCM2: F: GATACCCTGTCACCAACTTCTG; R: GAAGCCATCTGTCTCTTGAGG. 
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Hoxa3: F: TCAAGGCAGAACACTAAGCAG; R: ACTCCTTCTCCAGCTCTACC. 
Tbx1: F: TGGGACGAGTTCAATCAGC; R: TGTCATCTACGGGCACAAAG. 
Notch3: F: TTCCCCGTGTCGTAATGGTG; R: TCGAAGCCAGGAAGGCAAG  
Hey1: F: TGAGAAGCAGGGATCTGCTAAG; R: GCATTCCCGAAACCCCAAAC. 
Hey2: F: ACAGGGGGTAAAGGCTACTTTG; R: AGATGAGAGACAAGGCGCAC  
 
Whole-Transcriptome Shotgun Sequencing (RNA-seq) 
Total RNA was extracted following the manufacturer’s protocol of Direct-zol™ RNA 
MicroPrep kit (Zymo Research). Poly-A selected mRNA was purified and sequencing 
libraries were built using Illumina TruSeq RNA sample prep kit V2 (Illumina). Libraries 
were sequenced by single end 50-bp reads on Illumina HiSeq-2000. 
 
Bioinformatics 
For RNA-seq, low-quality reads (quality score below 20) were trimmed and reads shorter 
than 36 bp after trimming were filtered out. The remaining reads were further mapped. 
RNA-seq fastq files were generated by the Illumina pipeline (Casava 1.8). The reads 
were then mapped to mouse genome (mm9) by Tophat2 (Kim et al., 2013). Splicing 
junctions are from RefSeq annotation. Number of reads falling into each gene was 
counted using custom scripts. Then differentially expressed genes were called using 
edgeR (Robinson et al., 2010)(fold change ≥ 2 and FDR < 0.05). GO term analyses of 
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Chapter 5: Development of a low-cell-number epigenome profiling method 
 
This work has been published and I am listed as a co-first author.  
Zheng, X., Yue, S., Chen, H., Weber, B., Jia, J., and Zheng, Y. (2015). Low-Cell-Number 




Understanding how chromatin modification regulates development and disease 
can be limited by available material. Despite recent progress, balancing high quality and 
reliable mapping using chromatin-immunoprecipitation-based deep sequencing (ChIP-
seq) remains a challenge. We report two techniques, Recovery via Protection (RP)-ChIP-
seq and favored amplification RP-ChIP-seq (FARP-ChIP-seq), that provide reproducible 
mapping in as few as 500 cells. FARP-ChIP-seq accurately mapped histone H3 lysine 4 
trimethylation (H3K4me3) and histone H3 lysine 27 trimethylation (H3K27me3) in long-
term hematopoietic stem cells (LT-HSCs), short-term HSCs (ST-HSCs), and multi-potent 
progenitors (MPPs) from one mouse. These datasets indicate a lack of 












Mapping of epigenome modifications or chromatin regulator/transcription factor 
binding in a pure cell population is critical for basic and translational research. The 
ability to map epigenome changes in a cell population during development can shed light 
on the steps by which different cell lineages establish their transcriptional programs. 
Mapping the epigenome in a few cells isolated from diseased or healthy tissues may 
allow the discovery of specific disease-associated changes. Unfortunately, since ChIP-seq 
requires multi-step manipulations, DNA loss due to irreversible absorption or degradation 
has made it difficult to reliably obtain high quality mapping in only a few cells (Park, 
2009).  
ChIP-seq using standard methods requires nanograms of DNA: equal or greater 
than 10
6
 cells are needed for reliable and high quality ChIP-seq (Park, 2009). Various 
strategies have been developed to reduce the cell number needed. One method is to 
amplify the cells derived from tissues in vitro. Although this is applicable for 
progenitor/stem cell populations, it is not useful for dissected post-mitotic cells. Culturing 
and proliferation in vitro may also change progenitor/stem cells, potentially making the 
genome-wide studies unrepresentative of cells in vivo. Several methods have been 
developed to facilitate ChIP-seq using thousands or tens of thousands of cells. One of 
them relies on increasing DNA amplification cycles (Adli et al., 2010; Ng et al., 2013; 
Shankaranarayanan et al., 2012; Shankaranarayanan et al., 2011), which may introduce 
bias as low abundance ChIP DNA may be underrepresented or lost. Another method 
utilizes carrier proteins, chemicals, and/or mRNA during ChIP (Zwart et al., 2013), but 
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the absence of carrier during post-ChIP processing still leads to significant DNA loss, 
thereby compromising ChIP-seq quality.  
A third method, called indexing-first ChIP-seq (iChIP-seq) (Lara-Astiaso et al., 
2014), uses barcoding and pooling of multiple samples to study the epigenome in 
multiple hematopoietic lineages. Although the method reduces DNA loss by sample 
pooling, relying on sorting of fixed cells and sequential ChIP may still lead to DNA loss. 
Additionally, the on-bead ligation of adapters to chromatin fragments may reduce 
efficiency. Indeed 10-20K sorted hematopoietic cells were used in these iChIP-seq 
datasets (Lara-Astiaso et al., 2014). Finally, micrococcal nuclease (MNase)-base native 
ChIP (ultra-low-input micrococcal nuclease-based native ChIP, ULI-NChIP) was also 
used for epigenetic mapping (Brind'Amour et al., 2015). While the quality of ULI-
NChIP-seq for some epigenetic modifications is reasonable, other modifications were not 
mapped, indicating that the loss of ChIP DNA during manipulations could have resulted 
in variable outcomes. Here we report a new ChIP-seq method for high fidelity genome-
wide profiling using as few as 500 cells, and report its applications. 
 
Results 
Recovery via Protection (RP)-ChIP-seq for 500 cells  
An effective way to protect DNA from loss during ChIP-seq is to use agents that 
behave like DNA and which co-purify with chromatin or the DNA of interest during 
ChIP and library building. This would prevent the loss of DNA due to non-specific 
irreversible absorption and degradation by residual contaminating DNAses. One 




Figure 5-1. Analyses of carrier DNAs. (A) Whereas Drosophila genomic DNA 
sequences can be mapped to many regions in the Mus musculus (mouse) or Homo sapiens 
(human) genome, a very small number of S. cerevisiae or E. coli genomic sequences can 
be mapped to the genomes of Drosophila, mouse, or human. Synthetic biotin-DNA 
sequences are designed to not match to these genomes. (B) Analyses of yeast chromatin 
with H3K4me3. (C) The normalized H3K4me3 densities are plotted within the 2.5 Kb 







result in the presence of carrier DNA in the sequencing library, the carrier DNA 
sequences can be easily filtered out computationally after deep-seq if they do not map to 
the genome of interest. We compared various genomes, including mouse, human, 
Drosophila, yeast, and bacteria with one another.  We generated artificial reads  
by scanning the genome using a 50 base pair (bp) sliding window. Using Bowtie 
(Langmead et al., 2009) and allowing 3 mismatches, we mapped the Drosophila 
sequences to other genomes. 
Due to sequence conservation, many short reads derived from the Drosophila 
genome mapped broadly to mammalian genomes (Figure. 5-1A), so chromatin from 
Drosophila and mammalian genomes cannot be used as protection agents for one another. 
However, very few reads from S. cerevisiae (yeast) and E. coli were mapped to human, 
mouse, or Drosophila genomes (Figure. 5-1A). Importantly, over 90% of the few short 
mapped reads are in rDNA or simple repeat regions of target genomes. Since ~30% of 
yeast chromatin carries histone H3 lysine 4 trimethylation (H3K4me3) (Figure. 5-1B and 
C) and since commercial antibodies can successfully ChIP H3K4me3 from yeasts to 
human, as proof of principle, we used yeast chromatin as a carrier in the ChIP-seq of 
H3K4me3 in a small number of mouse embryonic stem cells (mESCs). We refer to this 
ChIP-seq as Recovery via Protection (RP)-ChIP-seq.  
We mixed formaldehyde cross-linked yeast (~5x10
7
) with either 500 or 2000 
cross-linked mESCs. Following sonication, antibody to H3K4me3 was used to ChIP both 
the yeast and mESC chromatin using standard ChIP and library building procedures. The 
similar patterns of H3K4me3 distribution around the transcriptional start sites (TSS) 





Figure 5-2. RP-ChIP-Seq. (A) Heatmaps of H3K4me3 on 5 Kb upstream and 
downstream of TSS in 10
7
, 2000, or 500 mESCs, rank ordered based on H3K4me3 in 10
7
 
mESCs. (B) Contour plots (Spearman correlation coefficient, R) of H3K4me3 on 
promoters by RP-ChIP-seq in 500 or 2000 mESCs at the indicated mouse reads and the 
standard ChIP-seq in 10
7
 mESCs at 163 million reads. (C)-(D) Plots of H3K4me3 peaks 
on chromosome 17 (C) or the enlarged region boxed in red in C using 500, 2000, and 10
7
 
mESCs (D).  
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standard ChIP-seq of 107 mESCs (Jia et al., 2012) (Figure. 5-2A), show that RP-ChIP-
seq successfully mapped H3K4me3 in 500 or 2000 mESCs. Importantly, increasing read 
depth resulted in further improvements of RP-ChIP-seq quality as indicated by increased 
correlation between RP-ChIP-seq and standard ChIP-seq of 107 cells (Figure. 5-2B). 
With 2.4 and 1.2 million mapped mouse reads, the correlation coefficient between the 
standard ChIP-seq of 107 mESCs and RP-ChIP-seq for 2000 and 500 mESCs reached 
R=0.976 and 0.952, respectively (Figure. 5-2A). Analyses of specific chromatin regions 
also showed that RP-ChIP-seq uncovered H3K4me3 peaks reliably (Figure. 5-2C and D).  
 
Favored Amplification RP-ChIP-seq (FARP-ChIP-seq) reduces read depth and is 
applicable to all mapping needs 
The RP-ChIP-seq described above effectively preserved the chromatin of interest, 
but it requires a substantial increase of total reads to obtain sufficient reads of the DNA of 
interest. It is not universally applicable for ChIP-seq mapping of other epigenomes and 
transcription-factor binding since yeast chromatin does not share all epigenetic 
modifications as animal genomes. We thus used a biotinylated synthetic DNA (biotin-
DNA) to replace the yeast chromatin. We designed 210-bp biotin-DNA that does not map 
to Drosophila, mouse, or human genomes. Since only a few endogenous biotinylated 
proteins have been found and none or few of them are associated with chromatin (Jia et 
al., 2012; Kim et al., 2009; Rybak et al., 2005), by mixing the biotin-DNA with 
chromatin, it was possible to recovery the biotin-DNA and the chromatin of interest using 
streptavidin beads and antibody-coupled protein G beads, respectively. To inhibit 




Figure 5-3.  Favored amplification (FA) RP-ChIP-seq (FARP-ChIP-seq). (A) Top: 
the biotin-DNA carrier annealed to the blocker oligo carrying a 3’ modified 3-carbon 
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spacer and 5’ 3 phosphorothioate modifications (asterisks). Bottom: cells of interest (red) 
were mixed with bacteria (blue), fixed, washed, and sonicated. Biotin-DNA bound to 
strepavidin beads and antibody-bound protein G beads were added for ChIP. (B) FARP-
ChIP-seq resulted in increased ratios of mapped mouse reads to total reads. (C)-(D) 
Contour plots (as log2 of the average read density within 2 Kb upstream and downstream 
of TSS. Spearman correlation coefficient, R) between two biological replicates of FARP-
ChIP-seq in 500 mESCs (C) or between 500 mESC FARP-ChIP-seq and the 10
7
 mESCs 
standard ChIP-seq (D). (E) Enrichment at the indicated genes on chromosome 6 were 
















complementary to the biotin-DNA was designed to contain phosphorothioate 
modification of the first 3 nucleotides at the 5’-end to resist the exonuclease activity of 
the PCR enzyme while a modified nucleotide carrying 3-carbon spacer at the 3’-end was 
designed to inhibit extension of the oligonucleotide by PCR (Figure. 5-3A). Indeed, when 
added at 0.25 M during library amplification, the blocker oligo reduced the 
amplification of the biotin-DNA by over 99% (data not shown). We refer to this method 
as favored amplification RP-ChIP-seq (FARP-ChIP-seq). 
We mapped H3K4me3 in 500 mESCs using FARP-ChIP-seq. Since H3K4me3 
exhibits sharp peaks near promoters, the total chromatin marked by H3K4me3 is lower 
compared to other histone modifications, which leads to difficulty in library building 
using low cell numbers. Indeed, the ULI-NChIP method obtained a H3K27me3 library 
from ~1000 mESCs but was unsuccessful for H3K4me3 mapping using the same cell 
number (Brind'Amour et al., 2015). Successful H3K4me3 mapping indicates that our 
method is also applicable for other histone modifications. To efficiently recover the small 
number of mESCs and their chromatin, we added ~5x10
8
 bacteria as cell carrier to 500 
mESCs followed by fixation, wash, and sonication (Figure. 5-3A). After ChIP using 
biotin-DNA-bound Steptavidin beads and protein G beads coupled to H3K4me3 
antibodies, blocker oligos were added during library building (Figure. 5-3A). FARP-
ChIP-seq resulted in a ~160-fold increase of mouse genomic DNA reads compared to 
RP-ChIP-seq at the same read depth for 500 mESCs (Figure. 5-3B). The biological 
replicates were highly consistent (Figure. 5-3C). The blocker oligo did not affect the 
quality of the FARP-ChIP-seq data because the biological replicates were highly 





 mESCs (Figure. 5-3C and D). The genome browser view also shows a 
high correlation (Figure. 5-3E).  
 
FARP-ChIP-seq offers the highest quality H3K4me3 map to date in hematopoietic 
stem cell subtypes sorted from one mouse 
Next we tested whether FARP-ChIP-seq could accurately map the epigenome of 
sub-types of hematopoietic stem cells (HSCs) sorted from one mouse. HSCs support life-
long production of all blood cells. Very little is known about genome-wide epigenetic 
regulation during early hematopoiesis because of the small numbers of cells that can be 
sorted from bone marrow (BM). For example, only ~0.1% of BM cells are HSCs, which 























 (LSK HSCs). The LSK HSCs 
(~30,000/mouse) consist of three functionally distinct subpopulations: long-term HSCs 
(LT-HSCs), short-term HSCs (ST-HSCs), and multi-potent progenitors (MPPs), which 
represent 0.007% (~2000/mouse), 0.04% (~12000/mouse), and 0.05% (~15000/mouse) of 
total BM cells, respectively (Yang et al., 2005). Three studies have mapped the HSC 
epigenome. The Nano-ChIP-seq mapped H3K4me3, H3K27me3, and H3K36me3 in 
20000 mixed-population LSK HSCs (Adli et al., 2010). Of the two recent studies, one 
mapped H3K4me3, H3K27me3, and H3K36me3 in subpopulations of LSK HSCs pooled 
from many mice using standard ChIP-seq (Sun et al., 2014), while the other mapped 
H3K4me1, H3K4me2, H3K4me3 and H3K27ac in LT-HSCs, ST-HSCs, and MPPs 





Figure 5-4. FARP-ChIP-seq of HSC subtypes. (A) FACS plots with the markers and 
gating used for sorting LSK HSCs, LT-HSCs, ST-HSCs, and MPPs. (B) The number of 
 
 146 
sorted LT-HSC and ST-HSC used in FARP-ChIP-seq determined by low-depth genome 
sequencing. (C)-(E) Contour plots (Spearman coefficient, R) between H3K4me3 on 
promoters obtained (plotted as log2 of the average read density within 2 Kb upstream and 
downstream of TSS) by FARP-ChIP-seq in two biological replicates of LT-HSCs (C), 
ST-HSCs (D), and MPPs (E). (F)-(G) MDS-plot of FARP-ChIP-seq (F) or iChIP-seq (G) 
H3K4me3 maps in LT-HSCs, ST-HSCs, and MPPs. Distances between biological 
replicates (-1 and -2) within and between HSC subtypes show the similarity/differences 
among the datasets. iChIP-seq of LT-HSCs and MPPs have no biological replicate, while 
the ST-HSCs biological replicates (-1 and -2) do not cluster together. (H) A summary of 
FARP-ChIP-seq and iChIP-seq of H3K4me3 in LT-HSCs and ST-HSCs with the cell 
numbers, antibody sources, and library complexities. (I) Genome-browser view of 
representative iChIP-only H3K4me3 peaks in LT-HSCs that overlaps with the iChIP 












Assuming that all the reported ChIP-seq qualities are high, the epigenome maps 
obtained by pooling sub-populations of HSCs from several mice at different ages or using 
mixed LSK HSCs may not accurately determine the epigenome of LT-HSCs, ST-HSCs, 
or MPPs. We thus applied FARP-ChIP-seq to map H3K4me3 and H3K27me3 in LT-
HSCs, ST-HSCs, or MPPs sorted from one 8-week old C57BL/6J mice. To avoid cross 
contamination of HSC subtypes, we gated stringently during sorting and based on the 
estimated cell numbers by flow cytometry, ~1500 LT-HSCs, ~6000 ST-HSCs, and 
~10000 MPPs could be sorted from one mouse (Figure. 5-4A). Since flow cytometry 
cannot accurately count the relatively rare LT-HSCs and ST-HSCs in one mouse, we 
developed a method that accurately determined the number of these cells in the input 
samples for FARP-ChIP-seq to be 800-1200 LT-HSCs and 1200-1500 ST-HSCs (Figure. 
5-4B). For MPPs, we used one fourth of the total sorted cells for one FARP-ChIP-seq, 
which corresponded to 2000-2500 cells.  
We found highly consistent FARP-ChIP-seq maps for H3K4me3 between 
biological replicates in the three HSC subtypes (Figure. 5-4C-E). A multi-dimension 
scaling plot (MDS-plot) showed good clustering of replicates (Figure. 5-4F), indicating 
that the H3K4me3 peaks are distinct in LT-HSC, ST-HSC, and MPPs. The only reported 
maps of H3K4me3 in LT-HSC, ST-HSC, and MPPs utilized iChIP-seq, in which the BM 
cells pooled from several 8-12 week-old mice were first labeled, fixed, and then sorted 
for the three HSC subtypes. iChIP-seq was performed using 10,000-20,000 sorted LT-
HSC, ST-HSC, or MPPs. Since the iChIP-seq used the same markers to sort LT-HSC, 
ST-HSC, and MPPs, we compared our FARP-ChIP-seq maps to those of iChIP-seq.  
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 We first determined whether the iChIP H3K4me3 dataset could distinguish LT-
HSCs, ST-HSCs, and MPPs. Only one sample for LT-HSCs and MPPs were available in 
the iChIP study. Nonetheless, the MDS-plot revealed that the two biological replicates for 
ST-HSC iChIP-seq failed to cluster, whereas the biological replicates of the FARP-ChIP-
seq datasets clustered well (Figure. 5-4F-G). Consistent with the MDS plot, no 
differential H3K4me3 peaks were identified among the iChIP-seq H3K4me3 datasets 
obtained for LT-HSCs, ST-HSCs, and MPPs, whereas hundreds of differential peaks 
were found in the FARP-ChIP-seq datasets. 
We next used the ‘preseq’ software package (Daley and Smith, 2013) to estimate 
the iChIP-seq H3K4me3 library complexity based on the deposited datasets (Lara-
Astiaso et al., 2014). The iChIP library complexities for LT-HSCs, ST-HSCs, and MPPs 
are 2.5-6.5M (million reads) (Figure. 5-4H). If the recovery rates of ChIP DNA were 
constant for different numbers of input cells, this would translate to 250-650K library 
complexity for 1000 cells, which would suggest that iChIP-seq might not perform well 
using low cell numbers. By contrast, our FARP-ChIP-seq library complexities for the 
HSC subtypes ranged from 14M to 60M using 800-1500 input cells (Figure. 5-4H). Since 
we used an H3K4me3 antibody different from that in the iChIP study, we repeated the 
FARP-ChIP-seq using the same antibody used by iChIP-seq. The library complexity 
obtained using 1500 ST-HSCs was 7.3M, which was higher than the highest complexity 
of 6.4M obtained by iChIP-seq of 10,000-20,000 cells (Figure. 5-4H). This indicates that 
FARP-ChIP-seq offers more accurate epigenome mapping in fewer cells.  
To ensure high recovery of live-sorted rare HSC subtypes during fixation and 
washes, we used bacteria as cell carriers in FARP-ChIP-seq, whereas a large number of 
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labeled BM cells were fixed, washed, and sorted for HSC subtypes in iChIP-seq. 
Although fixing and washing large numbers of BM cells prevents cell loss, fixation 
changes the fluorescence of cell surface labels and is also not compatible with propidium 
iodide (PI) or DAPI staining used for dead cell exclusion. Thus fixation could result in 
increased impurity of the sorted cells. We reasoned that lineage-signature based on 
H3K4me3 could allow us to assess cell purity used in iChIP-seq and FARP-ChIP-seq. By 
comparing the H3K4me3 datasets for LT-HSCs, we found 10,718 shared, 1,252 FARP-
ChIP-only, and 4,963 iChIP-only peaks. GO-term analyses of the FARP-ChIP-only peaks 
showed no significant enrichment of genes belonging to any terms, whereas the iChIP-
only peaks were enriched for genes involved in B-cell activation and proliferation, 
including key B-cell regulators such as Pax5, Ebf1, Ikzf3, Cd74, and B-cell marker genes 
such as Cd19 (Figure. 5-4I), suggesting a potential B-cell contamination of the LT-HSCs 
in the iChIP-seq. Next, we compared the iChIP-only H3K4me3 peaks in LT-HSCs to the 
total iChIP-seq H3K4me3 peaks determined for B cells in the same study (Lara-Astiaso 
et al., 2014). Among the top 20% highest LT-HSCs iChIP-only peaks, which are unlikely 
resulted from random noise, 95% overlapped with the B-cell H3K4me3 peaks (data not 
shown). Similar analysis suggests that one of the ST-HSC samples used in iChIP-seq also 
have B-cell contamination. These analyses demonstrate that FARP-ChIP-seq allows high 
quality epigenome mapping in a low number of sorted pure HSC subtypes because it does 





High quality H3K4me3 mapping by FARP-ChIP-seq offers a resource for studying 
HSC subtypes 
Since the broadest H3K4me3 peaks often mark genes important for the function 
and identity of a given cell type (Benayoun et al., 2014), we further mined the H3K4me3 
maps obtained by FARP-ChIP-seq for LT-HSCs, ST-HSCs, and MPPs. GO-term analysis 
showed that all broad H3K4me3 peaks in LT-HSCs, ST-HSCs, and MPPs were enriched 
in hematopoietic functions. For example, genes important for HSC regulation such as 
Meis1, Hlf, and Erg, all exhibited broad H3K4me3 peaks (Figure. 5-5A) in all three HSC 
subtypes. Thus, by looking for genes with broadest H3K4me3 peaks in our datasets, one 
may identify new candidate regulators of HSC for further functional studies.  
By comparing ST-HSCs and LT-HSCs, we identified 725 up- and 788 down-regulated 
H3K4me3 peaks (fold change>1.5, FDR<0.05). Among the genes exhibiting increased 
H3K4me3 peaks in ST-HSCs, we found those involved in cell-cycle regulation and DNA 
replication such as E2f8, Smc2, and Chek1 (Figure. 5-5B). Consistently, previous RNA-
seq showed an increased expression of genes that belong to these functional groups 
(Cabezas-Wallscheid et al., 2014). Interestingly, we found that multiple regulators of 
chromatin organization such as Cbx5 and Suv39h1 exhibited increased H3K4me3 (Figure. 
5-5B), suggesting that ST-HSC may have more condensed chromatin structure than LT-
HSC. GO-term analysis of differential promoter H3K4me3 peaks between LT-HSC and 
ST-HSC also supports the functional differences in cell cycle and chromatin organization 





Figure 5-5. Comparison of H3K4me3 between HSC subtypes. (A) Genome browser 
view of common broad H3K4me3 peaks on genes in the HSC subtypes. (B)-(E) Genome 
browser view of H3K4me3 differences on genes in the HSC subtypes (B, D) and GO-
term of genes with significant changes of promoter H3K4me3 between indicated HSC 
subtypes (C, E). Green, red, or blue bars, ST-HSC or LT-HSC, or MPP enriched GO-




When the H3K4me3 datasets between ST-HSCs and MPPs were compared, we 
identified 878 up- and 881 down-regulated peaks (fold change>1.5, FDR<0.05) in MPPs. 
Among the genes with down-regulated H3K4me3, we found known regulators of HSC 
generation, maintenance, or survival, such as Gata2 and Tal1 (Figure. 5-5D) (Porcher et 
al., 1996; Tsai and Orkin, 1997), had the broadest peaks in LT-HSC and ST-HSC. This 
suggests that H3K4me3 changes on these genes are responsible for preparing MPPs for 
multi-lineage differentiation. However, genes such as Ikzf1 and Dntt that are known to be 
required for lymphoid lineage functions exhibited an increase in H3K4me3 in MPPs 
(McCaffrey et al., 1975; Reynaud et al., 2008). Interestingly, GO-term analysis of 
differential promoter H3K4me3 peaks further revealed enrichment of genes required for 
mRNA metabolism and cell cycle in MPPs (Figure. 5-5E). Taken together, the high 
quality H3K4me3 maps obtained by FARP-ChIP-seq provide useful resources for the 
study of LT-HSCs, ST-HSCs, and MPPs. 
 
A general lack of H3K4me3/H3K27me3 bivalency in HSCs on genes required for 
hematopoietic differentiation 
 The marking of genes required for lineage specification and development by both 
H3K27me3 and H3K4me3 on their promoters was first discovered in mESCs (Bernstein 
et al., 2006). This so-called bivalent epigenetic mark is implicated in poising 
developmental regulators for rapid up- or down-regulation, and is thus considered to be 
important for lineage differentiation (Bernstein et al., 2006). Several studies have 
suggested the existence of bivalent genes in other stem/progenitor cells, but the co-




Figure 5-6. Genes for hematopoietic lineage differentiation are not generally 
marked by H3K4me3/HK27me3 bivalency in HSCs. (A)-(C) Contour plots (Spearman 
correlation coefficient, R) between H3K27me3 (plotted as log2 of the average read 
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density within 5 kb upstream and downstream of TSS) on promoters obtained by FARP-
ChIP-seq in biological replicates of the HSC subtypes. (D)-(F). Scatter plots of H3K4me3 
and H3K27me3 enrichment (plotted as log2 of the average read density within 2 Kb 
upstream and downstream of TSS) based on FARP-ChIP-seq in the HSC subtypes. (G) 
Genome browser view of bivalent genes found by FARP-ChIP-seq in the HSC subtypes 
and by previous studies. Rectangles outline the bivalent promoters. (H) Bar plot showing 




















established only in mESCs (Voigt et al., 2012). Whether the reported bivalency for other 
stem/progenitor cells reflects true dual marking or cell heterogeneity remains unclear. 
The studies that reported bivalent genes in HSCs used total LSK HSCs or purified 
sub-populations of LSK HSCs (Adli et al., 2010; Sun et al., 2014; Weishaupt et al., 2010).  
Overall, ~740-2260 bivalent genes were found in HSCs or its subtypes. Since the 
biological replicates of FARP-ChIP-seq maps of H3K27me3 were highly consistent 
(Figure. 5-6A-C), we analyzed H3K27me3/H3K4me3 bivalency using our datasets. We 
found that LT-HSCs, ST-HSCs, and MPPs had only 302, 376, and 117 bivalent genes, 
respectively (Figure. 5-6D-F). Among these, Rhpn2, Zfp580, Rassf5, and Gata3, were 
reported as bivalent genes previously (Sun et al., 2014; Weishaupt et al., 2010) (Figure. 
5-6G). When analyzing how many of the known mESC bivalent genes were resolved in 
the three HSC subtypes, we found that 605-662 and 1677-1757 of them became 
H3K4me3-only or H3K27me3-only genes, respectively. Whereas 58-184 of the mESC 
bivalent genes remained bivalent, 257-468 of them had neither modification in the three 
HSC subtypes (Figure. 5-6H). Importantly, the bivalent genes uncovered by FARP-ChIP-
seq are not implicated in regulating hematopoietic lineage development and GO-term 
analysis revealed no significant enrichment of pathway genes. Moreover, when all 
bivalent genes were combined in the three HSC subtypes, the 562 total bivalent genes 
identified by FARP-ChIP-seq were still smaller than the number previously reported for 
HSCs.  
To confirm whether H3K4me3/H3K27me3 bivalency is not used to mark the 






Figure 5-7. Analyses of H3K4me3 and H3K27me3 bivalent genes found in SP-
CD150
+
-LSK HSCs. (A) GO-term analysis of the H3K4me3 and H3K27me3 bivalent 
genes. (B) Heatmap showing the 3’-RNA-seq reads (reads per million, RPM) of the top 
300 H3K4me3-enriched bivalent genes in the SP-CD150
+
-LSK HSCs. Each row 
represents a gene and each column represents the RNA-seq for the indicated cell type. 
Only 72 out of 1940 genes were expressed in at least one of the 16 cell types. The last 









previously by focusing on the dataset obtained for a sub-population of LSK HSCs 




-LSK HSCs) (Sun et al., 2014). 
Since no bivalent gene list was provided in the mapping of the SP-CD150
+
-LSK HSCs 
(Sun et al., 2014), we first used our criteria to identify bivalent genes in the published 
dataset. We found 1940 promoters with both H3K4me3 and H3K27me3 enrichment in 
SP-CD150
+
-LSK HSCs, similar to the reported number of bivalent genes (Sun et al., 
2014). Among these, 210 overlapped with the bivalent genes found in our dataset, 
whereas the remaining genes had only H3K27me3 enrichment (91.7%, 1587 of 1730) in 
our dataset. Strikingly, GO-term analyses revealed that the 1940 bivalent genes were not 
enriched for hematopoietic differentiation or development, but were instead enriched for 
the differentiation/development of nervous system followed by epithelia, skeletal system, 
kidney, mesenchymal cells, urogenital system, heart, pancreas, and kidney (Figure. 5-7A). 
Among the 1940 bivalent genes, we selected 300 with the strongest H3K4me3 and 
compared them to the available RNA-seq datasets of the hematopoietic lineages and 
found that only 72 were expressed in at least one lineage (Figure. 5-7B) (Lara-Astiaso et 
al., 2014). This is consistent with the idea that genes required for non-hematopoietic 
lineage development are silenced in HSCs and the differentiated hematopoietic lineages. 
Based on our dataset, most of the 1940 bivalent genes are marked only by the repressive 
H3K27me3, so these analyses further confirm that H3K4me3 and H3K27me3 are not 
used to mark the poised state of genes required for hematopoietic lineage differentiation 






The ChIP-seq method reported here is based on the idea that if a rare cell 
population is not lost during the initial fixation and wash steps, and if chromatin loss is 
minimized during ChIP and library building, it should be possible to uncover low 
abundance DNA without increasing DNA amplification cycles. Although we report only 
epigenome mapping using FARP-ChIP-seq, the general principle of using synthetic DNA 
as carrier is applicable to all ChIP-seq, genomic DNA-seq, and RNA-seq needs when a 
single cell or a small number of cells are used. The presence of bacteria DNA and bio-
DNA in the final sequencing library calls for  ~5-fold increase in read depth for FARP-
ChIP-seq of 500 cells, and read depth is decreased as cell number used increases. 
Considering that FARP-ChIP-seq offers the highest fidelity mapping compared to all 
other methods for low cell numbers, this modest increase in sequencing depth justifies its 
application.  
Various carrier approaches have been employed to ensure the recovery of small 
amounts of DNA or RNA in different applications. In the specific case of ChIP-seq, we 
show that DNA or chromatin carrier ensures co-purification of carriers with the DNA of 
interest in each step. Since the carrier has the same characteristics to the DNA of interest, 
it can effectively occupy non-specific and irreversible DNA binding sites present on all 
surfaces and they can also saturate contaminating DNases. Here we show that RP-ChIP-
seq and FARP-ChIP-seq allows accurate mapping of epigenome in as few as 500 cells. 
We believe that with additional optimization and in conjunction with microfluidic 
techniques (Aguilar and Craighead, 2013), it should be possible to further reduce read 
depth and cell number needed in a high throughput format.  
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The FARP-ChIP-seq allowed us to reveal the high quality maps of H3K4me3 and 
H3K27me3 using low number of LT-HSCs, SH-HSCs, and MPPs compared to 
previously published datasets. By using pure cell populations, we found fewer 
H3K4me3/H3K27me3 bivalent genes in HSCs than previously reported. More 
importantly, the bivalent genes found in both our study and the reported studies are not 
involved in hematopoietic lineage specification. This shows that H3K4me3/H3K27me3 
bivalency is unlikely to be the mechanism used for poising lineage-specific gene 
expression in HSCs. However, it is possible that other mechanisms are used to poise 
genes for expression. For example, in hematopoietic cells such as the established EML 






negative marks (Orford et al., 2008). RNA polymerase II pausing on 
promoters may also poise genes for expression (Puri et al., 2015). The FARP-ChIP-seq 
strategy reported here should aid in the further study of how HSCs poise genes for 
lineage differentiation.   
 The methods reported here should allow large-scale epigenome association 
studies using pure cell populations from patients or animal models. Reduced cell 
heterogeneity should increase the success rate of discovering epigenetic changes that are 
relevant to either developmental or disease processes. The feasibility of mapping the 
epigenome of dissected tissues or sorted cells will allow improved understanding of 
epigenetic changes during each stage of organ and tissue building. Coupling such 
information with gene expression studies should greatly enhance our understanding of the 
developmental processes. The disease-associated epigenetic changes mapped with 
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dissected tissues, in conjunction with GWAS, should greatly improve the accuracy and 
power of biomarker discovery and disease diagnosis. 
 
Materials and methods 
Standard ChIP-seq 
Standard ChIPs were performed according to conditions suggested by manufacturers of 
ChIP-grade antibodies to H3K27me3 (Millipore, 07-449) and H3K4me3 (Cell Signaling, 
9751). Briefly, formaldehyde was added to mESCs to crosslink proteins to DNA and the 
cells were lysed in 200 µl lysis buffer (50 mM HEPES, pH 7.5, 140 mM NaCl; 1 mM 
EDTA; 1% Triton X-100; 0.1% sodium deoxycholate; 0.1% sodium dodecyl sulfate). 
Cell lysates were sonicated using a Bioruptor ultrasonic cell disruptor (Diagenode) to 
shear genomic DNA to an average fragment size of 150 to 250 bp and ChIP was 
performed following protocol provided by Millipore ChIP Assay kit (Millipore, 17-295). 
After washing and de-crosslinking, the precipitated DNA was purified using a QIAquick 
PCR purification kit (QIAGEN). 
 
RP-ChIP-seq 
500 or 2000 mESCs were mixed with ~5x10
7
 S. cerevisiae and fixed in 1% formaldehyde 
for 10 minutes at room temperature. After fixation and washes, the mixtures were 
sonicated with a 1/8 inch probe for a total of 15 min at 9 watts using a tip sonicator 
(Misonix sonicator 3000) to obtain genomic DNA fragments with an average size of 150-
250 bp. Buffers and buffer volumes were according to standard ChIP procedures. After 
ChIP, libraries were prepared following Illumina True-Seq protocol with 10 PCR 
amplification cycles. The libraries were sequenced using an Illumina HiSeq2000 with 
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single-end and 50 bp read length. 
 
FARP-ChIP-seq 
mESCs (500 or 1000) or sorted HSC subtypes were mixed with ~5x10
8 
DH5a E.coli and 
fixed in 1% formaldehyde for 10 min at room temperature. After fixation and washes, the 
mixtures were sonicated with a 1/16-inch probe for 15 min at 3 watts using a tip sonicator 
(Misonix sonicator 3000) to obtain genomic DNA fragments with an average size of 150-
250bp. Buffers and buffer volumes were according to standard ChIP procedures. The 
lysates were incubated with 2 µl H3K27me3 antibody (Millipore, 07-449) or 1 µl 
H3K4me3 antibody (Cell Signaling, 9751S) overnight at 4°C. At the meanwhile, 60 µl 
protein G magnetic beads (Life Technologies, 10004D) and 10 µl M-280 streptavidin 
beads (Life Technologies, 11206D) for each ChIP were prepared for the next step. To 
block any non-specific chromatin absorption, protein G beads and M-280 streptavidin 
beads were pre-incubated with ~5x10
8 
fixed and sonicated E.coli lysate overnight at 4°C, 
respectively. After blocking step, 5 ng carrier biotin-DNA was then coupled to 10 µl M-
280 streptavidin beads according to manufacturer’s instruction (Life Technologies, 
11206D). These treated protein G and streptavidin beads were combined and used to 
ChIP H3K27me3 or H3K4me3 in the sonicated E.coli+mESC or E.coli+HSC lysates for 
4 h at 4°C. The beads were then recovered using a magnetic stand. All washing, de-
crosslinking were performed following standard ChIP procedures. After decrosslinking, 
the precipitated genomic DNA and biotin-DNA were purified using Agencourt AMPure 
XP beads (Beckman Coulter). Library building steps were performed following True-Seq 
protocol with 12 PCR amplification cycles. 0.25 mM blocker oligo was added at the final 
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library amplification step. 




The amplification blocker sequence 
5’A*C*A*AATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAA
-3 carbon spacer 3’ 
*indicate the first three phosphorothioated DNA bases. 
 
Isolation of HSC subtypes for FARP-ChIP-seq 
Femora and tibiae were dissected from one C57BL/6J male mouse (8 weeks old) and 
bone marrow cells were flushed with FACS buffer (PBS with 0.3% BSA and 2 mM 
EDTA). The cells were enriched with CD117/c-Kit MicroBeads following the guidelines 
(Miltenyi Biotec, #130-091-224). c-Kit enriched cells were stained with lineage cell 
detection cocktail-biotin (Miltenyi Biotec, #130-092-613) for 20 min at 4oC. Cells were 
stained with DAPI, anti-Biotin, c-Kit, Sca1, CD34, and Flk2 antibodies (Biolegend) for 
20 min followed by sorting with FACSAriaTM III cell sorter (BD Bioscience). The cell 
populations collected were: LT-HSC: Lin-, c-Kit+, Sca-1+, CD34-, Flk2-; ST-HSC: Lin-, 
c-Kit+, Sca-1+, CD34+, Flk2-; MPP: Lin-, c-Kit+, Sca-1+, CD34+, Flk2+. 
 
Determining the number of HSC subtypes used in FARP-ChIP-seq 





 bacteria and fixed in 1% formaldehyde for 10 min at room temperature. After 
fixation and washes, the mixtures were sonicated using the same conditions for HSC 
subtypes. The sample was then used to build library for low-depth genomic sequencing. 
A cell number standard was determined using the number of reads from mouse and 
bacteria by linear regression. To prevent the loss of sorted LT-HSCs, ST-HSCs, and 
MPPs during fixation and wash steps, each subtype was mixed with 5x10
8
 bacteria and 
fixed followed by washes to remove the fixative. After sonication, 5% of each sample 
was used for the same low-depth genomic sequencing as above. The mouse and bacteria 
reads obtained in each sample were used to determine the number of HSC subtypes based 
on the cell standard. 
 
Quality-filtering, mapping, and analyses of all ChIP-seq datasets in this study 
For RP-ChIP-seq and FARP-ChIP-seq libraries, reads were filtered using the quality of 
multiplexing indices before mapping to prevent contamination by erroneous de-
multiplexing. Reads with an average index quality below 30 were discarded (Kircher et 
al., 2012).The reads were then mapped to mouse genome (mm9) by Bowtie, allowing 2 
mismatches per read. Only uniquely mapped reads were retained. The mapped reads were 
further mapped to carrier genome or biotin-DNA sequences by Bowtie allowing 3 
mismatches, and reads mapped to the carrier genome or biotin-DNA was discarded.  
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